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ABSTRACT
Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
represent a spectrum of acute inflammatory microvasculature lung injury which
occur in an unpredictable manner in predisposed individuals following a number of
disparate insults which are often remote from the lung itself. It is currently thought
that circulating factors precipitate a systemic inflammatory response resulting in a
pan-endothelial injury which accounts for their frequent association with multiple
organ dysfunction syndrome (MODS). Although the incidence of ARDS is low,
therapeutic options are limited, care is mainly supportive and the prognosis is poor.
Impact on this dreadful situation is most likely to arise from research focusing the
events which belie the initiation and perpetuation of the pulmonary inflammatory
response, thereby facilitating the development of novel mechanism based therapies
which may be delivered at the earliest stages in the development of lung injury.
Such research has been hampered by the fact that currently used diagnostic criteria
do not address the underlying pathophysiogical events and are thus not only non¬
specific but are insufficiently sensitive to the earliest stages of evolving
inflammatory injury. Studies based on these criteria may thus encompass a
population of patients who do not have true ARDS, but also exclude patients who
suffer lesser forms of lung injury which arise from similar mechanisms and whose
study might reasonably provide important information on the resolution of
pulmonary inflammation.
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One of the earliest pathophysiological events in the pathogenesis of acute
inflammatory lung injury is damage to the delicate pulmonary endothelium with a
resultant breakdown in the alveolar-capillary barrier leading to flooding of the
pulmonary interstitum and alveolar airspace with a protein rich fluid. Techniques
have been developed which utilise externally situated gamma detectors to chart the
transit of radiolabelled proteins from the intravascular space to the pulmonary
interstitium which provide a non-invasive and dynamic measurement which is both
sensitive to and specific for the detection of inflammatory pulmonary oedema.
Although of recognised importance in the evaluation of patients at-risk of and with
established ARDS, such techniques have not been widely adopted. Although the
reasons have not been documented, this may reflect the expense involved in the
purchase of the equipment and radioisotopes and the limited accessibility of such
equipment in a busy Intensive Therapy Unit.
The aim of this thesis was to assess the applicability of a fully portable dual isotope
system which utilises three miniature scintillation detectors in the recording of
pulmonary microvascular permeability. Recordings were carried out in the Intensive
Care and High Dependency setting from patients both with established ARDS and
from a group of patients at-risk ofALI/ARDS. In patients at-risk of ARDS I
examined the hypothesis that it is possible to identify a subgroup of patients in whom
a subclinical inflammatory response will be associated with the emergence of
pulmonary microvascular permeability and also whether the occurrence of
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pulmonary permeability represents a forme fruste which fails to progress or whether
it is a reliable indicator of impending severe lung injury. Furthermore, in both
groups of patients I wished to investigate whether the occurrence of enhanced
microvascular permeability may be correlated with key inflammatory markers which
may support contentions for their role in the pathogenesis of lung injury and also




1.1 THE DEFINITION OF ARDS.
The acute respiratory distress syndrome (ARDS) is a catastrophic form of acute
microvascular inflammatory injury which forms a central component of multiple
organ failure. It was almost certainly first recognised in young men catastrophically
wounded in conflict situations who developed acute severe respiratory distress
following multiple trauma and burn injury (Brewer et al. 1946), but the first
published description of ARDS has been attributed to Ashbaugh and colleagues
(Ashbaugh et al. 1967) who described twelve patients with acute respiratory distress
characterised by severe dyspnoea, tachypnoea, cyanosis refractory to the
administration of oxygen, decreased compliance of the respiratory system and diffuse
alveolar infiltrations on the chest radiograph. They reported pathological findings in
seven patients which included atelectasis, vascular congestion and haemorrhage,
severe pulmonary oedema and hyaline membrane formation. This original report
included one child, but a more detailed account of the condition was provided by the
same centre, almost four years later, in which the authors changed the nomenclature
of the condition substituting 'acute' with 'adult' (Petty et al. 1971). This was later
regretted by the first author and has been corrected in the latest definition of the
syndrome (Bernard et al. 1994).
1.1.1 Clinical features of ARDS
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ARDS is described in a wide variety of clinical settings comprising both direct and
indirect pulmonary injuries (Table 1.1), and characteristically becomes clinically
apparent following a latent period, usually between 12-24 hours, after the initiating
event (Fowler et al 1983). The underlying pathological reaction is complex
involving multiple cellular and humoral mediators but at a tissue level is
characterised by inflammatory injury to the alveolar-capillary membrane with a
resultant increase in permeability to protein and solutes. The complexity of the
pathological reaction and the contribution of individual elements remain to be clearly
elucidated. As a result attempts to define ARDS have concentrated on the major
operational features of the disorder such as the degree of hypoxaemia, the appearance
of the chest radiograph and the compliance of the respiratory system. The central
pathophysiological event, increased pulmonary permeability, is generally inferred by
exclusion of factors likely to attribute to cardiogenic oedema.
A major advance in our understanding of ARDS came in 1988 with the proposition
of an expanded definition based on three critical distinguishing features of the
disorder (Murray et al. 1988). The first incorporated epidemiological data which
suggested that two major groups of patients could be identified: those who make a
prompt recovery and generally have a favourable prognosis and those who develop a
chronic fibrotic illness. The majority of the mortality occurred in the latter group
(Montgomery et al. 1985). This led to the classification of patients suffering from
ARDS as either 'Acute' or 'Chronic'. Furthermore, the second feature in the expanded
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definition came from an appreciation that lung injury was not of equal magnitude in
all patients. A 'lung injury score' was formulated and the term ARDS attributed to
those patients with only the most severe form of lung injury. (Table 1.2) The third
part of the expanded definition allowed recognition, if it were known, of the
underlying cause. (Table 1.3)
The merits of the expanded definition included an acknowledgement of the phase and
aetiological precipitant of the disease which clearly had prognostic implications for
the patient. In addition, the use of the lung injury score facilitated a grading of the
severity of lung injury. The Pa02/Fi02 ratio avoided arguments over the correct level
at which hypoxaemia could be defined and the chest radiographic score represented
some assessment of the presence and severity of oedema. Although the compliance
of the respiratory system was not essential, it again provided information on the
severity and course of the disease. The value of the pulmonary artery catheter in the
clinical management of patients was unquestioned, but the investigators recognised
that it was inappropriate to base the diagnosis of ARDS on the value obtained and
thus excluded this measurement from the diagnosis. The reasons for this will be
explained in section 1.8.4.
In 1992 the first meeting of a consensus conference ofNorth American and European
investigators further refined the definition, particularly focusing on the spectrum of
severity of lung injury (Table 1.4) (Bernard et al. 1994). Recognising that a
continuum of lung injury existed they proposed the diagnostic entity of 'Acute Lung
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Injury' (ALI) which was of lesser severity but shared similar precipitants and clinical
course to ARDS. They also clarified the confusion regarding the term adult and
recommended that investigators revert to the term 'acute'. A further
recommendation was that all patients with a Pa02/Fi02 of less than 200 in the absence
of left heart failure and/or interstitial lung disease should be considered to have
ARDS regardless of the extent of their radiographic abnormalities and without
making any allowance for the effect of positive end expiratory pressure on the Pa02.
1.1.2 Problems with the Definition of ARDS
Although considerable advances have been made in our understanding of
inflammatory lung injury, both ALI and ARDS remain descriptive terms based on
clinical criteria which do not address the underlying pathophysiological events
pertinent to the development of inflammatory lung injury. The diagnosis usually rests
on the appearance of the chest radiograph and arterial blood gases but these are both
non-specific reflecting merely deranged pulmonary function without alluding to the
cause. Although attempts have been made to ascribe a degree of specificity to certain
appearances of oedema seen on the chest radiograph, these are often deceptive when
applied to the individual patient (discussed in section 1.8.3) and other abnormalities
which appear, such as ground glass opacification and pulmonary consolidation are
seen in many other conditions which may occur independently, or co-exist with
ARDS (Joffe. 1974, Putman. 1992). Inclusion of the pulmonary artery wedge
pressure may provide an indirect assessment of the contribution of hydrostatic factors
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to the clinical picture, but interpretation of this data may be misleading (discussed in
section 1.8.4). The chest radiograph is also known to be insensitive to the earliest
stages of lung injury when it is frequently normal (Greene et al. 1987). Furthermore
the chest radiograph provides only a static record with no information on the
dynamics of oedema formation/resolution. Whilst the pathology of ARDS has been
documented in a number of studies (Hill et al 1976, Tomasheski. 1990) the
difficulties associated with routine diagnostic biopsy in these patients precludes
attempts to obtain structural information such as the presence of diffuse alveolar
damage (DAD). Thus the current definition of ARDS remains imprecise and non¬
specific.
1.1.3 The epidemiology ofARDS
Controversy surrounding the definition of ARDS has led to variable estimates of
incidence ranging from 1.5-3.5 per 100 000 population (Villard et al. 1989) to 75 per
100 000 population (Ashbaugh. 1972). Most authors quote a figure of 5-7 per 100
000 of the population (Osborne and Meyer. 1996). The recognition that lesser forms
of lung injury constitute a similar though less severe form of the same disease
process will undoubtedly lead to the identification of a greater number of cases
(Bernard et al. 1994). Indeed, with the appreciation that the currently available
techniques fail to identify a large subpopulation of patients with inflammatory lung
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injury, those patients with clinically apparent ARDS have been likened to the tip of
the iceberg in which a much larger number of subclinical cases remain to be
identified.
1.1.4 Therapy in ARDS
The past thirty yeas have witnessed a dramatic improvement in the reception and
initiation of care of the critically ill, particularly due to improvements in ventilatory
modalities and other aspects of supportive care within the Intensive Therapy Unit.
Studies are beginning to report improvements in survival rates for patients who suffer
ARDS, particularly younger individuals with trauma-induced ARDS (Sloane et al.
1992, Milberg et al. 1995) although average survival figures remain around 50
percent. Nevertheless, the care of such patients continues to represent a significant
drain on the Intensive care budget and exert a considerable human burden on both the
relatives and carers of patients of succumb. In addition, those patients whilst some
patients may make a dramatic and full recovery many are left with substantial
pulmonary morbidity (Sloane et al. 1992, Hert and Albert. 1994, McHugh et al.
1994,)
Successful therapy for patients with ARDS would be likely to reap substantial
economic benefit in addition to relieving the suffering of patients and their relatives.
Considerable effort has been directed towards this goal but unfortunately little real
progress has been made. Pharmacological agents have been delivered by both the
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systemic and inhaled routes. Large trials of non-steroidal anti-inflammatory drugs
and corticosteroids have been disappointing although there may be a role for
corticosteroids for those patients who progress to the later fibroproliferative phase of
the disease (Bernard et al. 1987, Bone et al 1987, Luce et al. 1988, Bone et al. 1989,
Meduri et al. 1994). Encouraging reports observed with inhaled nitric oxide, a potent
pulmonary vasodilator (Rossaint et al. 1993) await the result of further randomised
controlled trials. More recently the potential role of aerosolised surfactant therapy
has been examined and regrettably found to be without benefit (Anzueto et al. 1996).
Improvements in supportive care have included the development of ventilatory
strategies directed towards improved systemic oxygenation and limiting further
pulmonary barotrauma to the already damaged lung. Such strategies include, inverse
ratio ventilation, in which the inspiratory phase is extended at the expense of a
shortened expiratory phase (Cole et al. 1984, Lain et al. 1989) and high frequency jet
ventilation employing rapid (at least 60 breaths per minute) ventilatory bursts with a
tidal volume approximating to that of the anatomical dead space (Carlon et al. 1983).
The use of extracorporeal membrane oxygenation (ECMO) continues to be used in
certain centres in the USA with apparent success but controlled studies have
demonstrated little difference between patient treated with ECMO and the control
group (Morris et al. 1994).
Although further improvements in supportive modalities are to be expected, a major
challenge for physicians and intensivists is to understand the earliest mechanisms in
23
the disease process which lead to the initiation and perpetuation of the acute
inflammatory response. This in turn should lead to improved and earlier recognition
of impending lung injury and the development of novel mechanism based therapies
which could potentially be delivered at an earlier time point when it may be more
realistic to expect lung injury to be attenuated or aborted (Reid et al 1995 (b)).
Thus in the remainder of this introductory chapter I intend to concentrate on what is
known about the pathogenesis of the ARDS, highlighting the role of the endothelium
and the principle effector cell, the neutrophil.
1.2 THE PATHOGENESIS OF ACUTE LUNG INJURY
1.2.1 Overview
ARDS is a catastrophic form of acute inflammatory microvascular lung injury which
evolves rapidly involving a complex network of inflammatory cells and mediators.
The earliest pathological events are believed to occur within the pulmonary
microvascular bed where inflammatory injury to the delicate pulmonary endothelial
and epithelial surfaces results in the leakage of protein rich fluid from the
intravascular space to the pulmonary interstitium and alveolar airspaces. This leads
to the appearance of bilateral interstitial shadowing on the chest radiograph and
severe impairment of gas exchange, often requiring the administration of high
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concentrations of oxygen and mechanical ventilation. Although at this stage some
individuals will recover, others progress rapidly to a chronic phase. Alveolar type I
cells are lost and replaced with the proliferation of type II alveolar pneumocytes
leading to thickening of the alveolar septum. The interstitium becomes infiltrated
with mesenchymal, inflammatory and other cells including fibroblasts which
proliferate and deposit new scar matrix proteins which obliterate the alveolar,
alveolar ducts and the pulmonary interstitium (Zapol et al 1979, Fukudu et al. 1987).
Alterations are also seen in the pulmonary vasculature including the obliteration of
the capillaries and thrombosis contributing to pulmonary hypertension (Tomashefski
et al. 1983, Bachofen et al. 1974, Fukudu et al. 1987). Such extensively injured
lungs are prone to develop secondary infection and many individuals progress within
a systemic inflammatory response to multiple organ failure (Figure 1.1).
1.2.2 The Endothelium in Acute Lung Injury
At its most simple level the endothelium provides a selectively permeable barrier
between the pulmonary interstitium and the intravascular space which facilitates the
efficient regulation of gas exchange by the alveolar units. Breakdown of the integrity
of this barrier function leading to flooding of the alveolar airspace therefore has
serious consequences for the efficient function of the lungs but the endothelium is
also known to play a central role in the acute inflammatory response.
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As early as 1889, Cohnheim realised the importance of the endothelium in the
regulation of the inflammatory response. Observing that focal injurious or
inflammatory stimuli produced a localised inflammatory response and that the
microvasculature downstream of the stimulus was uninvolved, he speculated that
"inflammation is the expression and consequence of a molecular alteration in the
vessel walls (Cohnheim. 1889). The explosion in endothelial cell biology in recent
years has begun to elucidate the mechanisms by which the endothelium participates
and regulates the inflammatory response.
The quiescent endothelium provides an antithrombotic, non-adhesive surface.
Inflammation reverses the endothelial cell phenotype to promote the coagulation
cascade and express adhesion molecules involved in the recruitment of leucocytes
and other inflammatory cells. Many of the inflammatory signals which prime and
activate inflammatory cells also promote the upregulation of endothelial adhesion
molecules. For example both interleukin-1 (IL-1) and tumour necrosis factor (TNF)
mediate the upregulation of endothelial adhesion molecules involved in the earliest
phases of recruitment of inflammatory cells to the lung (Mantovani et al 1992).
In addition to the inflammatory response, endothelial damage in its broadest sense is
likely to affect the synthesis of endothelial cell components. As such they may be
used as markers of severity of endothelial cell injury in ARDS as reviewed in section
1.4.
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1.2.3 ARDS as a Pan-endothelial Injury
The observation that many cases ofARDS arise from indirect pulmonary insults such
as pancreatitis or perforated viscus lead to the concept that a circulating humoral
factor must be involved in the pathogenesis of the disease. Thus it was anticipated
that a global microcirculatory injury may occur in which ARDS merely represents
the pulmonary component. Support for this theory has come from several studies in
which significant structural alterations (accompanied by accumulation of neutrophils)
have been documented in multiple organs following experimental sepsis or acute
lung injury.
In an animal model of acute lung injury induced by intravenous administration of
phorbol myristate acetate (PMA) Mizer and colleagues demonstrated that significant
structural alterations occur in non-pulmonary organs (Mizer et al. 1989). Moreover
these non-pulmonary organ changes developed concomitantly with acute lung injury
and were associated with marked increases in parenchymal neutrophil accumulation.
St John and colleagues demonstrated that this neutrophil accumulation was
associated with a functional counterpart by demonstrating significant alterations in
intestinal microvascular permeability in several animal models of acute lung injury.
(St John et al. 1991, St John et al. 1993) Human cadaver evidence from patients
who succumb within hours from their injuries suggests that the lungs are not the only
organs affected by an inflammatory process (Nuytinck et al. 1988). The concept of a
global microcirculatory injury is also borne out by the clinical experience. ARDS
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and multiple organ dysfunction syndrome (MODS) share similar risk factors and
ARDS is often associated with or may lead to MODS (Figure 1.1) (Gill and Sibbald.
1996).
1.2.4 The lung is the major target of a pan-endothelial injury
If such a concept of a global microcirculatory injury is operative, the question as to
why the lungs are so often the first and principle organ to be involved must be
addressed. Several factors are likely to be contributory.
The pulmonary circulation contains a large endothelial surface area which, at any one
time, is in close proximity to a resident pool of neutrophils. Even in health, a
subpopulation, which may be up to 50 % of the circulating neutrophils, are
temporarily sequestered within a 'marginated pool' in close apposition to the
pulmonary capillaries and thus systemic mediators are likely to act first upon this
resident pool. Furthermore the lungs receive the entire cardiac output such that any
such mediator will pass through the pulmonary circulation in high concentration. In
addition the delicate structure of the alveolar unit is such that minor changes may
result in a marked impairment of function.
1.3 INFLAMMATORY CELLS IN ARDS
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1.3.1 The Neutrophil
A large body of evidence has amassed to implicate the neutrophil as a key effector
cell in the pathogenesis of ARDS. Histological specimens taken from patients in the
earliest stages of the disease display an intense neutrophilic infiltrate (Holter et al.
1986). Similarly, bronchoalveolar lavage fluid demonstrates a preponderance of
neutrophils (Lee et al. 1981) as well as the neutrophil secretory products, elastase
(Rocker et al. 1989) and collagenase (Christner et al. 1985). Furthermore, BAL
neutrophilia has been shown to correlate with markers of disease severity including
the degree of pulmonary permeability to proteins and the lung injury score (Sinclair
et al. 1994).
In patients at-risk of ARDS, inflammatory markers of neutrophil activation and
recruitment show potential to facilitate the identification of those patients at highest
risk of ARDS progression. Bronchoalveolar lavage (BAL) fluid from patients
suffering either multiple trauma, perforated bowel or pancreatitis with elevated levels
of the neutrophil chemotaxin, interleukin-8 (IL-8), are at significantly higher risk of
progression to established ARDS than those who do not (Donnelly et al. 1993).
Similarly low levels of circulating soluble L-selectin, a neutrophil adhesion marker
involved in the early stages of neutrophil-endothelial adhesion, also provide
predictive potential for ARDS progression (Donnelly et al. 1994).
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1.3.2 Other inflammatory cells
Although at first sight the case for the neutrophil may appear conclusive, as ARDS
has been reported in neutropenic patients (Braude et al. 1985), thus the neutrophil is
unlikely to represent the sole effector cell. Whether these patients represent a
separate subgroup of ARDS or whether small numbers of neutrophils in the
pulmonary tissues are sufficient to provide the critical link in a pathogenic sequence
is unknown (Haslett. 1992).
1.3.3 Recruitment of Inflammatory Cells to the Lung
In order for neutrophils and other inflammatory cells to induce lung injury, they must
first be recruited from the vascular space and migrate into the pulmonary
parenchyma. This multistage event is facilitated by both the biophysical properties
of the neutrophil and the pulmonary circulation but also by the complex interplay
between different groups of adhesion molecules present on the endothelial and
inflammatory cell (MacNee and Selby 1993). The mean diameter of the neutrophil is
7-8 pm (Schmidt-Schonbein et al. 1985) and that of the pulmonary capillary 5.5pm
(Guntheroth et al. 1982), thus in order to transit through the pulmonary circulation
the neutrophil must deforme. Experimental models and human studies have
demonstrated that decreased neutrophil deformability increases neutrophil
accumulation in the capillaries (Downey and Worthen. 1988, Downey et al. 1990),
and reduced transit time through the lung (Selby 1991).
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The contribution of adhesion molecules to neutrophil recruitment has largely been
elucidated in the systemic circulation, but is also likely to play a key role in the lung
(Figure 1.2). It is presently thought that molecules of the Selectin family are
responsible for the earliest stages of leucocyte-endothelial adhesion and those of the
integrin family, the later 'tight' adhesive phase which is a prelude to neutrophil
transmigration. The known selectin family currently comprises three structurally
related cell surface molecules involved in neutrophil-endothelial adhesion. Their
nomenclature relates to the cell type on which the selectins were first described
(Bevilacqua et al. 1991). P-selectin was first identified on activated platelets (Hsu-
Lin et al. 1984, McEver et al. 1984), but was later found to be expressed on activated
endothelium (McEver et al. 1989). E-selectin was first identified as a cytokine
inducible molecule on the endothelium which facilitated the adhesion of neutrophils
(Belvilacqua et al. 1987). L-selectin was first identified as a molecule responsible
for the homing of lymphocytes into lymph nodes (Gallatin et al. 1983) and later
recognised to play a key role in the early stages of neutrophil-endothelial adhesion in
response to inflammatory stimuli (Kishimoto et al. 1989). Evidence that
constitutively expressed neutrophil L-selectin interacts with its corresponding ligand
on the endothelium to facilitate neutrophil deceleration and 'rolling' was provided by
the development of specific monoclonal antibodies which resulted in a significant
inhibition of early neutrophil/endothelial adhesion and a consequent reduction in
neutrophil transendothelial migration (Lawrence et al. 1991). Following this short
term adhesion, specific up-regulation of neutrophil integrin adhesion molecules, e.g.
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CD1 lb/18 leads to firmer adhesion, bringing the circulating neutrophil to a halt and
facilitating neutrophil -endothelial transmigration (Smith et al. 1988). During the
transition to "tight" adhesion L-selectin is cleaved by a metalloprotease (Bennet et al.
1996) and exists in the circulation in a soluble form (sL-selectin) which continues to
exert biological activity by retaining the capacity to bind to activated endothelium
(Schleiffenbaum et al. 1992).
The importance of the selectin family has been further reiterated by the development
of animal models through gene targeting leading to so-called "knock-out" mice. Null
mutants of all three selectins have been produced in mice which confirm the
importance of the selectin family in the early inflammatory response (Frenette and
Wagner. 1997) and are likely to provide valuable insight into the role of the selectins
in the pathogenesis of several inflammatory disease states.
1.4 EVIDENCE FOR ENDOTHELIAL DAMAGE IN ARDS
A number of endothelial markers have been examined in the setting of established
ARDS. These include angiotensin converting enzyme (ACE), endothelin-1 (ET-1),
von-Willebrand factor antigen (vWfiAg) and thrombomodulin (Tm).
1.4.1 Serum Angiotensin Converting Enzyme
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Angiotensin converting enzyme (ACE), the enzyme responsible for the catabolism of
angiotensin I to angiotensin II, is synthesised by endothelial cells and expressed on
their luminal surface. The endothelium is the source of the activity of this enzyme in
the blood (Stewart et al. 1981). Thus it was hypothesised that the activity of this
enzyme in blood or BAL fluid could reflect pulmonary endothelial damage. Animal
models of acute lung injury demonstrated early acute rises in the circulating level of
serum ACE which, as lung injury progressed, decreased to levels below baseline
(Nukiwa et al 1982, Hollinger et al 1980, Gorin et al. 1981). Human studies have
also demonstrated a reduction in the specific activity of serum ACE but this is an
non-specific finding being seen in other critically ill patients (Casey et al. 1981,
Fourrier et al. 1983, Fourrier et al. 1985). Furthermore, blood concentrations of ACE
in patients with acute lung injury did not reliably reflect disease severity or predict
outcome (Fourrier F et al. 1985).
1.4.2 Endothelin-1 (ET-1)
Endothelin-1 is a potent vasoconstrictor peptide which is produced by the
endothelium in response to ischaemia (Miyauchi et al. 1989), endotoxic shock
(Morel et al 1989) and sepsis (Pittet et al. 1991). As it is predominantly metabolised
by pulmonary endothelial cells it has been suggested as an indicator of acute lung
injury (Sirvio et al. 1990). Elevated levels have been described in the setting of lung
injury, and indeed seemed to reflect the underlying severity (Druml et al. 1993).
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However ET-1 is non-specific with elevated levels also being described in pulmonary
hypertension (Giaid et al. 1993) and asthma (Kraft et al. 1994).
1.4.3 Von-Willebrand Factor Antigen
The human plasma coagulation Factor VIII circulates as a complex of Factor VIII
(VIII:C) and von Willebrand factor. Von Willebrand factor is a glycoprotein
composed of multimers of Factor VIII related antigen (VIIIR:Ag) that are essential
for platelet adhesion to damaged endothelium and platelet aggregation in the
presence of ristocetin. Although small amounts of vWf are produced by
megakaryocytes and platelets (Spom et al. 1985), it is predominantly synthesised by
the vascular endothelial cells (Bloom et al 1973). Increased circulating vWf have
been found in numerous studies where damage to the endothelium is thought to have
occurred (Blann. 1993). vWf may be assayed immunologically as von-Willebrand
factor antigen (vWfiAg) or functionally as ristocetin cofactor (vWTRiCoF). A
disproportionate rise in vWfiAg to vWfiRiCoF has been shown to occur in
respiratory failure and this is thought to indicate damage to the pulmonary
endothelium (Grant et al. 1978, Carvalho et al. 1982)
Carvalho examined the level of vWfiAg and vWfiRiCoF in 100 patients with acute
lung injury, 29 critically ill patients without lung injury and 60 normal controls.
They found that in normal and critically ill patients without evidence of lung injury
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the levels of vWf:Ag and vWf:RiCoF were closely correlated but in patients with
acute lung injury the levels of vWf:Ag were elevated disproportionately to the level
of vWf:RiCoF and the ratio of vWf:Ag:vWf:RiCoF increased with increasing
severity of lung damage (Carvalho AC et al. 1982). Further studies have confirmed
the role of vWf:Ag as a sensitive marker of endothelial cell injury and activation
(Hamilton et al. 1987, Ribes et al. 1987) but it should be noted that under some
experimental conditions vWf:Ag may also be released by the action of vasopressin
without concomitant vascular endothelial cell injury (Jones et al. 1992).
1.4.4 Thrombomodulin
Thrombomodulin (Tm) is a glycoprotein expressed on the surface of the endothelial
cell and functions as a high affinity receptor for thrombin with powerful
anticoagulant properties. When thrombin is bound to Tm, it activates protein C,
triggering the activation of factors Va and Villa and impairing the formation of new
thrombin. Furthermore Tm prevents the action of thrombin on fibrinogen, platelets
and factor V and therefore clot formation.
Thrombomodulin is widely distributed on the endothelium of human arteries, veins,
capillaries and lymphatics in all organs and tissues except the brain. The highest
content of TM are found in the lung and human placenta (Maruyama et al. 1985).
Elevated circulating levels of Tm have been described in a variety of disease states
characterised by damage to the endothelium, including ARDS (Takano et al 1990,
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MacGregor et al. 1997). Furthermore, the expression of Tm is known to be
modulated by agents implicated in the pathogenesis of ARDS including TNF, IL-1,
endotoxin (Dittman. 1991, Sawada et al. 1992) and recently primed activated
neutrophils (MacGregor et al. 1997).
Thrombomodulin may be cleaved from endothelial cells and circulates in the plasma
in soluble form (Ishii et al. 1985). The precise physiological role of this soluble form
is still unclear however it appears that release of soluble of forms of thrombomodulin
into the circulation reflects endothelial damage and not endothelial activation (Ishii et
al. 1991).
1.4.5 E-selectin
E-selectin or endothelial-leucocyte adhesion molecule-1 (ELAM-1) is a 115 kDa
glycoprotein which is involved in the mediation of early endothelial-leucocyte
adhesion. It appears to be an endothelial cell specific. It is not expressed on resting
endothelium but is inducible after stimulation with various inflammatory mediators
including endotoxin, IL-1 and TNF alpha (Wong et al. 1991, Montgomery et al.
1991). In vivo, a constitutive low level of E-selectin expression appears to play a
role in normal leucocyte trafficking (Frenett et al 1996).
The importance of E-selectin in the mediation of neutrophil influx was demonstrated
by Mulligan and colleagues in a rat model of acute lung injury induced by the
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deposition of IgG immune complexes . This model, which displays similarities to
clinical ARDS, is critically dependent upon the activation of neutrophils and their
physical contact and adherence to the endothelium. Using this model Mulligan and
colleagues demonstrated the administration of both a monoclonal antibody to E-
selectin or sialylated oligosaccharides which block the ligand of E-selectin (also
shared by P-selectin) significantly reduced the amount of neutrophil extravasation
and vascular permeability (Mulligan et al 1991, Mulligan et al. 1993)
A shed, soluble form ofE-selectin (sE-selectin) may be detected in the supernatant of
activated endothelial cells (Piggott et al. 1992) and a low level is present in the
plasma of normal individuals (Newman et al. 1993). Several investigators have
documented elevated levels in critically ill individuals including those with sepsis
(Newman et al. 1993), the systemic inflammatory response syndrome (Cowley et al.
1994), and ARDS (Moss et al. 1996).
1.4.6 P-selectin
P-selectin is a glycoprotein of molecular weight 140 kD, that is stored in the alpha
granules of platelets and the Weibel-Palade bodies of endothelial cells and is rapidly
translocated to the surface of these cells when they are activated by a range of
mediators including TNF, oxygen radicals and thrombin ( Stenberg et al 1985, Geng
et al. 1990, Patel et al. 1991). As for E-selectin, a soluble form of P-selectin may be
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detected in the plasma (Dunlop et al. 1992) and elevated levels of sP-selectin have
been demonstrated in the plasma in acute lung injury (Sakamaki et al. 1995).
In a similar manner to E-selectin, the significance of P-selectin in the interaction
between neutrophils and the vascular endothelium has been demonstrated using a rat
model of neutrophil mediated lung injury induced by cobra venom factor.
Monoclonal antibodies to P-selectin or the carbohydrate ligand recognised by P-
selectin, significantly ameliorated neutrophil accumulation, extravascular leakage
and haemorrhage ( Mulligan et al 1992, Mulligan et al 1993)
1.5 ENDOTHELIAL MARKERS EXAMINED WITH A PREDICTIVE ROLE
FOR ARDS
Given that advances in the management of ARDS are likely to arise from an earlier
recognition of evolving lung injury, interest has focused on predictive indices. At a
pathological level the earliest events appear to arise in the pulmonary
microvasculature and the appearance of increased microvascular permeability is
presumed to reflect inflammatory damage to the delicate pulmonary endothelium.
As a result several groups have explored the possible role of circulating markers of
endothelium damage in the at-risk period.
1.5.1 von-Willebrand factor Antigen
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The potential of vWf:Ag to predict progression to lung injury was evaluated in a
prospective study involving a cohort of patients with non-pulmonary sepsis
syndrome (Rubin et al. 1990). A plasma level greater than 450% over control values
was 87% sensitive and 77% specific with a modest positive predictive value of 65%
for identifying patients with non-pulmonary sepsis and a normal chest radiograph
who subsequently developed acute lung injury although this rose to 80% when the
elevated plasma vWf:Ag was combined with the failure of at least one organ.
VWf:Ag is however unable to reliably predict impending acute lung injury in more
diverse groups of patients. In one series of 96 patients from multiple at-risk groups
analysis of VWf:Ag failed to identify those who subsequently progressed to ARDS
(Moss et al. 1995). In a further study of 21 patients with a multiplicity of risk factors
for ARDS, despite a vWf:Ag of > 450% in 6 of these patients, none progressed to
ARDS (Sabharwal et al. 1995).
1.5.2 Other endothelial markers
Circulating levels of E- and P-selectin were not found to be predictive of subsequent
progression to ARDS in patients suffering from multiple trauma, pancreatitis or
perforated bowel (Donnelly et al 1994). This finding was also observed in a study of
nineteen patients with sepsis and thirty-six suffering multiple trauma (Moss et al.
1996). In addition, we have previously examined the role of Tm in a group of fifty-
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eight patients at-risk ofARDS, from a cohort of patients comprising multiple trauma,
pancreatitis and perforated viscus and found that it was unhelpful in assisting with
the prediction of patients who subsequently progressed to ARDS (Reid et al 1995 a).
1.6 NEUTROPHIL MARKERS IN ARDS
1.6.1 Neutrophil elastase
The human neutrophils contains a large number of potentially histotoxic substances
(Haslett C et al. 1989) of which neutrophil elastase has emerged as one of the prime
candidates responsible for tissue injury. It has the ability to digest many of the
components of the alveolar-capillary membrane (Janhoff et al. 1979, Smedley et al.
1986) and has been found in large quantities in bronchoalveolar lavage fluid taken
from the lung of patients with established ARDS (Rocker et al. 1989). Elevated
circulating levels of neutrophil elastase [which represent a marker of neutrophil
degranulation (Jochum et al. 1984)] have been demonstrated in patients with
established ARDS (Zheutlin et al. 1986) as have elevated serum and BAL levels of
7S collagen, a N-terminal peptide of type IV collagen cleaved by HNE (Kawamura et
al. 1994, Konodoh et al. 1992).
1.7 NEUTROPHIL MARKERS IN PATIENTS AT-RISK OF ARDS
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1.7.1 Neutrophil elastase
Work from Edinburgh has demonstrated that in patients with severe multiple trauma,
the initial circulating elastase sampled during resuscitation in the Accident and
Emergency Department, assists in the identification of a sub-group who subsequently
progress to ARDS (Donnelly et al. 1995).
1.7.2 sL-selectin
Our group has previously demonstrated that patients who progress to ARDS have
significantly lower levels of circulating sL-selectin compared to those who do not.
Furthermore the level of sL-selectin is of prognostic significance, strongly correlating
with semiquantitative indices of lung injury (time spent on a mechanical ventilator,
the lowest Pa02/Fi02 ratio) and with subsequent mortality (Donnelly et al. 1994).
This low level may reflect widespread endothelial activation and binding of the
circulating receptor to its endothelial ligand. Thus, this circulating sL-selectin may
reflect important events occurring at the alveolar-capillary interface implicating
endothelial activation in the early ARDS disease process.
1.8 PERMEABILITY IN ARDS
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1.8.1. The Alveolar-Capillary Barrier
The arrangement of the alveolar-capillary barrier facilitates effective gas exchange
and fluid flux. It is composed of the pulmonary capillary endothelium, the alveolar
epithelium and their respective basement membranes (Fig 1.3). The interstitial space
between them is asymmetrically arranged around the capillaries such that on one side
the space is obliterated and the barrier is less than 0.5pm (facilitating efficient gas-
exchange), and on the other side the space is larger (l-2pm) and is thought to be the
site of fluid flux between the capillary and interstitium. Under normal circumstances
there is flow of both water and protein across the pulmonary endothelium into the
interstitial space, which is drained by the lymphatic system, but the balance of
hydrostatic and osmotic forces ensure that the alveolar-capillary barrier functions as a
semipermeable membrane, preventing the filtration of water and solute from the
blood and interstitial space into the alveoli. Pulmonary oedema only develops only
when the maximal lymphatic drainage rate is exceeded. This is summarised by the
Starling equation (Starling. 1896). The modern version of this is:
Qf = Kf [(pmv-Ppmv) - a (;rmv - 7ipmv)]
Q f = net transvascular water flow
Kf = microvascular membrane filtration coefficient
pmv = hydrostatic pressure in the microvessels
Ppmv = hydrostatic pressure in the interstitium
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Timv = oncotic pressure in the microvessels
Tipinv = oncotic pressure in the interstitum
a = reflection coefficient ( a measure of the resistance to solute flux)
The law is analogous to Ohm's law which states that Transvascular flow =
Conductance (K) x Driving Pressure. Applied to the alveolar-capillary barrier, the
driving pressure represents the difference between net transvascular hydrostatic
pressure (Pmv - Ppmv) and the net transvascular protein osmotic pressure a (7imv -
rtpmv)]- Normally , a positive hydrostatic pressure gradient (pmv-Ppmv) tends to move
liquid from the circulation to the interstitial space and this force is opposed by an
oncotic pressure gradient (7imv - 7ipmv) that promotes the movement of liquid back into
the vascular compartment. The net starling forces favour movement of liquid into
the pulmonary interstitium where it is drained by the lung lymphatics. In the presence
of an intact alveolar-capillary barrier the lung is relatively resistant to the
accumulation of alveolar oedema, even at elevated hydrostatic pressures (Staub et al.
1967 Taylor. 1981).
1.8.2 Pulmonary Microvascular Permeability and the Diagnosis of ARDS
In contrast to the normal situation described above, ARDS is characterised by
damage to the delicate pulmonary endothelial and epithelial surfaces with the result
that the protein reflection coefficient of the membrane (a) falls to zero, permeability
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to proteins and other solutes increases. The capillary filtration coefficient (K f) is also
increased, leading to a decrease in the opposing interstitial oncotic gradient. Fluid
flux becomes increasingly dependent on the hydrostatic pressure gradient allowing
lung oedema to develop even at low pulmonary microvascular pressures.
Despite the central role of increased pulmonary microvascular permeability in the
pathogenesis of ARDS, diagnostic techniques aimed at the detection and
quantification of enhanced lung leak have not been widely adopted, are only
available at a limited number of centres where they remain research tools. Thus, for
the most part, investigators continue to infer the presence of enhanced permeability
by exclusion of factors suggestive of hydrostatic (cardiogenic) oedema. This may be
performed on clinical grounds but is more often proposed on the basis of a low
pulmonary capillary wedge pressure although some investigators have suggested that
certain features on the chest radiograph may be sufficiently specific to enable
differentiation of cardiogenic from non-cardiogenic oedema. Both techniques,
however, have limitations which make them less than ideal on an individual basis.
1.8.3 The chest radiograph in increased permeability oedema
As an imaging system the chest radiograph has many advantages. It is widely
available, portable, reproducible, relatively cheap, and provides regional imaging.
Opinion remains divided as to whether the chest radiograph can reliably differentiate
between cardiogenic and non-cardiogenic oedema. The radiographic signs
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considered most discriminatory in one series included the pattern of blood flow, the
distribution of the oedema and the width of the vascular pedicle (Milne et al. 1985).
In 50% of cases of cardiogenic oedema blood flow appeared preferentially diverted
to the upper lobe vessels ( a so-called "inverted pattern") which was only seen in
10% of patients with ARDS. A peripheral distribution of oedema was the
commonest pattern observed in patients with ARDS but was rarely seen in patients
with cardiogenic oedema. Based on their overall findings the authors claimed an
overall accuracy of the chest radiograph of 86-89%. These findings are however at
variance with other studies using similar scoring techniques. Though the finding of a
patchy or peripheral distribution of oedema has been shown to be highly specific
(87%) for ARDS, its sensitivity is below 50% making it an unreliable sign when
applied to an individual patient (Aberle et al. 1988). In a similar manner the
discriminatory value of further radiographic signs of interstitial fluid accumulation
and pleural effusions have been questioned (Milne et al. 1985, Miniati et al. 1988,
Smith et al 1987, Aberle et al. 1988).
1.8.4 The pulmonary artery catheter in increased permeability oedema
The introduction of a flexible, balloon tipped catheter into the pulmonary artery was
first described by Jenkins and Bradley (Jenkins et al. 1970) but later popularised by
Swan (Swan et al. 1970) who demonstrated that measurement of the pressure distal
to an occluded balloon in the pulmonary artery (PAWP), correlated with the left
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atrial pressure (LAP) and hence the left ventricular end-diastolic pressure (LVEDP)
and thus had the potential to provide valuable haemodyanmic and diagnostic
information. The popularity of such catheters in clinical use is reflected by the fact
that over two million are currently sold world-wide (Ginosar and Sprung. 1996). In
the setting of ARDS, it was suggested that the finding of a low pulmonary artery
wedge pressure infers any radiographic oedema seen is secondary to increased
pulmonary permeability. However, for a variety of both technical and
pathophysiological reasons, the PAWP may not always adequately reflect the
LVEDP and may thus be misleading in individual patients (Raper and Sibbald.
1986). Furthermore, as the pulmonary artery catheter is often introduced several
hours after presentation, data obtained may not reflect the initial haemodynamic
profile of the patient (Dicpinigaitis PV. 1994). As mentioned, the expanded
definition (Murray et al. 1988) excluded measurements made by the pulmonary
artery catheter from the diagnostic algorithm.
Recently concern has been raised regarding the routine use of the pulmonary artery
catheter following a prospective cohort study of 1789 patients with acute respiratory
failure including ARDS and pneumonia was associated with an increased risk of
death (Connors et al. 1996). A recent consensus conference on the use of the
pulmonary artery catheter emphasised the ability of the correct use of the pulmonary
artery catheter to assist in the diagnosis of patients with respiratory failure but
recognised that the precise role of the catheter had yet to be defined (Pulmonary
Artery Catheter Consensus Conference Participants. 1997).
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Thus, the limitations of both the chest radiograph and the pulmonary artery wedge
pressure emphasise the requirement for further research into methods specifically
aimed at the detection of increased pulmonary microvascular permeability.
1.8.5 Techniques aimed at the Detection of Increased Pulmonary Microvascular
Permeability
Techniques to investigate pulmonary permeability may be divided into two broad
categories directed at either the epithelial or endothelial barrier. As the epithelial
barrier is thought to be the rate limiting step in the pathogenesis of alveolar flooding,
techniques which depend on sampling of alveolar or bronchial secretions most
probably reflect both endothelial and epithelial permeability.
(A) Epithelial Permeability.
The most widely accepted method of measuring pulmonary epithelial permeability
utilises a low molecular weight, water soluble solute diethylentriamine pentaacetic
acid (DTPA) radiolabeled with technetium-99m and delivered to the airways in the
form of a aerosol. The rate of clearance from the lung is then recorded by either
scintillation counters or a gamma camera. DTPA clearance is significantly
accelerated in patients with ARDS, but although exquisitely sensitive, it is very non¬
specific (Hunter et al 1990).
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(B) Endothelial permeability. The finding of high levels of protein in the oedema
fluid of patients with ARDS led to speculation that the transit of radiolabelled
proteins may assist in the quantification of pulmonary permeability. Anderson and
colleagues demonstrated a highly significant increase in the clearance rate of
radiolabelled albumin from patients with pulmonary oedema due to ARDS compared
to that of left ventricular failure. However their technique involved the sequential
sampling of tracheal aspirates which was time consuming and not necessarily
representative of the alveolar secretions (Anderson et al. 1979).
This technique has now been superseded by non-invasive methods. The basis of
these techniques was reported by Gorin (Gorin et al 1978). Working with a sheep
model of inflammatory lung oedema induced by Pseudomonas aeruginosa
bacteraemia, Gorin and colleagues used an externally situated gamma camera to
record the interstitial accumulation of the plasma protein transferrin labelled with
113In and found that it closely paralleled the concentration of protein measured
directly in the lung lymph. The technique was subsequently extended for use in man
(Gorin et al. 1980) and later simplified by Basran (Basran et al. 1985).
The principle of this technique depends on the assumption that the lung can be
considered as a two-compartment model: an intravascular and extravascular
compartment (Figure 1.4). A circulating plasma protein (commonly albumin or
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transferrin) is labelled with a suitable radionuclide and the accumulation of this
protein in the lung recorded by externally situated scintillation detectors. The count
rates detected over the lung field provide a measure of both the intravascular marker
and any which has accumulated in the pulmonary extravascular space. The
simultaneous recording of count rates from the radiolabelled protein over the cardiac
blood pool allow a correction for the normal clearance of the tracer from the
circulation. Furthermore as changes in blood volume will alter the levels of
recorded radioactivity detected by the probe(s), independent of changes in
transvascular protein flux or plasma protein clearance, count rates from radiolabelled
red blood cells are recorded in a similar manner. The ratio of the counts obtained
over the lung to those over the heart may be plotted graphically as a component of
time and the protein accumulation index mathematically derived (Figure 1.5). This is
termed the plasma protein accumulation index (PPA) or protein accumulation index
(PAI) and provides a dynamic non-invasive measurement of pulmonary
microvascular permeability. A more complete explanation of this technique is given
in section 2.5.1.
Applying a similar method to a dog model of inflammatory lung injury Dauber and
colleagues demonstrated that the technique was both specific and sensitive, able to
discriminate between hydrostatic pulmonary oedema and inflammatory pulmonary
oedema caused by thiourea injury. They also demonstrated that it was possible to
detect an almost doubling in pulmonary vascular protein leak prior to the appearance
of any measurable increase in lung water (Dauber et al. 1985).
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In man, the technique has been used to demonstrate a significant elevation of
pulmonary protein accumulation in 22 patients with ARDS (11 with post-mortem
evidence of diffuse alveolar damage) compared to 11 healthy volunteers (Rocker et
al. 1988 a). In a further study, the technique was used in association with circulating
and BAL markers of neutrophil activation to identify a graded intensity of pulmonary
permeability in 50 patients with a range of respiratory failure and risk factors,
supported the hypothesis that ARDS was not a distinct entity but rather a part of a
spectrum of respiratory failure in which pulmonary permeability and neutrophil
activation were related (Rocker et al. 1989). Further studies have shown that
permeability to proteins is elevated throughout the course of ARDS and is also
strongly related to the BAL neutrophil count and the lung injury score (Sinclair et al.
1994).
Other Techniques proposed to measure Pulmonary Permeability
PET Scanning
Positron emission tomography (PET) is based on the detection of the annihilation
radiation. The technique utilises positrons, positively charged short-lived electrons,
which readily combine with an electron to produce 2 gamma photons, each having an
energy of 511 keV and are emitted in directions 180° opposed to one another.
Although expensive, cumbersome and of limited availability, PET scanning is likely
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to provide the most accurate data on pulmonary permeability (Schuster. 1989). The
major advantage of PET scanning is the ability to obtain whole lung imaging and in
addition, the simultaneous use of two or more positron emitting isotopes allows
quantification of both protein leak and accumulation of extravascular lung water and
pulmonary vascular blood flow in the same study.
Velazquez and colleagues performed studies on an animal model of lung injury
induced by oleic acid. Using a PET scanner they demonstrated a strong correlation
between the pulmonary transcapillary escape rate and the proportion of structurally
abnormal alveoli as examined by both light and electron microscopy (Velazequez et
Calindrino and colleagues evaluated the pulmonary transcapillary escape rate
(PTCER) of 68Ga as an index of pulmonary microvascular permeability in 15 patients
with ARDS and 12 healthy non-smoking controls. They found the PTCER to be up
to 10 times greater than that of controls in the early phase of the disease, furthermore,
repeat studies between 7-12 days after the onset of ARDS demonstrated reductions
in the PTCER although it remained between 4-6 times greater than the controls
(Calandrino et al. 1988).
Low molecular weight dextrans.
al. 1991).
Abernathy and colleagues have investigated the feasibility of using radiolabeled
dextrans. Using an in-situ rabbit lung preparations, they recorded the accumulation
of 6 and 40 kDa dextrans, labelled with positron emitting isotope fluorine-18-fluoride
(1SF) by means of a gamma camera. They found that the small dextrans traversed the
microvascular membrane rapidly, leading to significantly reduced scan times which
would have the potential advantage of minimising motion artefact (Abemathy et al
1995). This technique has yet to be employed in the clinical setting but has great
potential since reduced scan times are likely to be significantly more user friendly to
ITU staff and have the potential to reduce errors produced by the repositioning of
probes in longer studies during which critically ill patients may require to be moved
to facilitate nursing or paramedical staff.
1.9 PULMONARY PERMEABILITY AND THE PREDICTION OF ARDS
The first attempt to assess pulmonary microvascular permeability in a prospective
manner was made in 1986 (Strum et al. 1986). Enrolling 22 patients with multiple
trauma admitted to the Surgical Clinic, Hanover Medical School, West Germany,
they prospectively evaluated lung capillary permeability by a radiolabelled albumin
technique (Sugerman et al. 1984). The values obtained were compared with other
physiologic parameters such as extravascular lung water (determined by the double
indicator thermodilution technique), dynamic lung compliance, and alveolar-arterial
oxygen tension gradients. Despite demonstrating variation between different
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individuals and different time periods in the same individual the study was able to
show that 87.5% of trauma patients demonstrated an abnormally elevated
transvascular protein flux within 24 hours. In contrast, other physiologic parameters
(including extravascular lung water) did not significantly deteriorate until 48-72
hours after trauma. The authors did not record progression to ARDS but this study
represented an important attempt to provide documentary evidence for the hypothesis
that the ARDS disease process was present prior to its clinical detection by other
commonly used parameters. In 1988, Basran and colleagues demonstrated that an
elevation in the protein accumulation index preceded the clinical appearance of
ARDS in one patient with severe burn injuries and one patient with multiple trauma
(Basran et al. 1988). In 1992, Braude and colleagues performed serial measurements
of pulmonary microvascular permeability on a patient with cryptogenic fibrosing
alveolitis who became febrile and breathless after an open lung biopsy and
subsequently progressed to fulfil diagnostic criteria for ARDS. They demonstrated
that an elevation in PAI preceded the radiographic deterioration and suggested that
the use of pulmonary microvascular permeability measurement may predict the
progression to ARDS.
Initial hopes that the measurement of protein accumulation might lead to earlier
recognition of impending lung injury have not been realised by further studies which
have tended to be small. In a study of ten patients undergoing cardiopulmonary
bypass surgery the protein accumulation index (PAI), in the post-bypass period, was
compared with other parameters of lung function. Whilst patients post-bypass
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demonstrated an elevated PAI, this did not correlate with other parameters of post¬
operative lung function. Despite this the patient who generated a PAI of 3.2 x 10-3
quickly developed severe cardiorespiratory failure and died 3 days post-operatively
(MacNaughton et al. 1992).
1.10 SUMMARY OF INTRODUCTORY CHAPTER
ARDS remains a dramatic disease and although uncommon, an important cause of
untimely death. It is not as once thought, a distinct pulmonary entity, but represents
the pulmonary component of a pan-endothelial injury, which in its most extreme,
leads to multiple organ failure. Furthermore, we now recognise that within the
context of the pulmonary component, a spectrum of lung injury exists with many
more patients developing a less severe form of lung injury: ALI.
The pathogenesis of ARDS is complex: a multiplicity of mediators have been and
continue to be described and the pathophysiological significance of many of these
remains to be determined. The identification of individuals in the earliest stages of
the disease process is likely to facilitate the identification of mediators critical to the
initiation and perpetuation of inflammatory lung injury. A key early event, central to
our understanding of ARDS is damage to the alveolar-capillary membrane resulting
in leakage of fluid and protein from the circulation into the pulmonary interstitium
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and alveolar airspaces. A number of techniques have been developed to record
alterations in permeability but none have made the transition from bench to bedside.
Consequently the recognition of ARDS continues to be based on the appearance of
the chest radiograph and arterial blood gases and increased permeability is inferred
by exclusion of factors which would otherwise point to cardiogenic oedema.
Aims of Study
Whilst significant progress has been made since the original description of ARDS in
1967, it is widely recognised that controversy continues to surround the diagnosis. In
part, this reflects the multiplicity of disparate risk factors for ARDS, but largely is
attributable to the fact that ARDS remains a clinical diagnosis and the criteria used
do not directly reflect the underlying pathophysiological events. Central to our
understanding of ARDS, and re-emphasised in the American-European Consensus
statement definition, is the appearance of increased permeability to protein and
solutes which results in flooding of the pulmonary interstitium and alveolar airspaces
with proteinaceous fluid leading to non-compliant lungs, impaired oxygenation and
diffuse radiographic appearances of oedema (Bernard et al 1994).. As yet a measure
increased microvascular permeability is not available for routine use in the diagnosis
of ARDS but in recognition of the importance and likely benefit of recording
pulmonary permeability the investigators stated that " because increased pulmonary
permeability is considered a hallmark of ALI, research into methods quantifying
altered permeability is encouraged."
55
The aim of this thesis was to investigate a method of recording pulmonary
microvascular permeability in patients both at-risk of, and with established ARDS
and to correlate measurements obtained with inflammatory markers likely to reflect
damage to the alveolar-capillary membrane. To this end, the evaluation of a fully
portable double isotope system with miniature caesium-iodide scintillation detectors
designed for ease of use in the ward and intensive care setting. The physical
characteristics of the system with the appropriate radioisotopes are presented in a
series of phantom experiments and bedside recordings obtained from normal
volunteers, patients with established ARDS and a patient group at-risk of ARDS. In
addition, the potential relationship between the recorded pulmonary microvascular
permeability and a range of pathophysiological markers reflecting gas exchange,
neutrophil activation and endothelial damage is investigated. Given the non-
























Table 1.1 Clinical Predispositions to Acute Lung Injury/Acute Respiratory




No alveolar consolidation 0
Alveolar consolidation confined to one segments 1
Alveolar consolidation confined to two segments 2
Alveolar consolidation confined to three segments 3
Alveolar consolidation in all four segments
2. Hypoxaemia Score
Pa02/Fi02 - > 40




3. PEEP Score (when ventilated)
PEEP - < 5 cmH20
PEEP - 6 - 8 cm H20
PEEP - 12 - 14 cm H20
PEEP - > 15 cm H20^
4. Respiratory System Compliance
Compliance - > 80 ml/ cmH,0
Compliance - 60 - 79 ml/ cmH20
Compliance - 40 - 59 ml/ cmH20
Compliance - 20 - 39 ml/cmH20
Compliance - < 19 ml/ cmH,0
The final score is obtained by dividing the aggregate sum by the number of
components that were used.
Classification Score
No Lung Injury 0
Mild to Moderate 0.1 -2.25
Severe >2.25



















1. Acute or Chronic, depending on course
2. Mild to moderate or severe lung injury depending on lung injury
score








































Table1.4Recommenedcrit riaf acutelunginj ry(ALI)acuteespi torydistr sssyndrome( RDS)prop sedthican- EuropeanConsensusf r nceARDS1994.
Cardiogenic oedema Non-cardiogenic oedema
Heart size
Vascular pedicle






















Table 1.5 Features on the plain chest radiograph which may assist in differentiating






Acute Inflammatory Microvascular Lung Injury
< >
Subclinical Mild Moderate Severe
+ / —
Faillure of other organ systems
None MOF
Death
No morbidity Persistent morbidity
Figure 1.1 The spectrum of acute lung injury. Acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS) develop in susceptible individuals, after a variable latent period, following a number
of disparate precipitating conditions. ARDS and multiple organ failure (MOF) share common risk
predispositions and may occur in the same individual. Mortality remains high and while some patients
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Figure 1.5 Representation of the graphs used in the calculation of the protein
accumulation index. In this example the indium ratio (ratio of indium counts detected
over the lung relative to those detected over the heart during the study period) has
increased but the technetium ratio (lung/heart counts for Tc) has remained the same
demonstrating that the intravascular volume did not change significantly during the study
period. The final indium/technetium ratio demonstrates an extravascular accumulation of





For the purposes of these studies the Mediscint System (Oakfield Instruments Ltd,
Oxford, U.K.) was chosen. This is an integrated system consisting of a personal
computer (PC) based multi-channel analyser linked to three miniature scintillation
counters (Figure 2.1). The system detects gamma radiation emitted by radio-labelled
pharmaceutical within the patients body and is capable of detecting and counting
from two radionuclides simultaneously. The mediscint software programme runs
under the Microsoft Windows 3.1 operating system and provides real time display of
acquired time activity curves. The data package facilitates analysis of the generated
curves.
2.1.1 Scintillation Detectors
Scintillation detectors utilise the property of phosphors (commonly sodium or
caesium iodide), which, when they absorb energy from ionising radiation, re-emit the
energy in the form of light. Phosphors cannot detect beta emissions but are very
sensitive for gamma emissions. The magnitude of the flash of light is converted to a
digital signal, proportional to the amount of energy deposited in the scintillator by
the radiation, and therefore provides a measure of the intensity. When connected to
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appropriate electronic circuitry, the detector can perform a spectrum analysis of the
energy of the radiation and distinguish between radiation's of different energies.
The Mediscint system utilises miniature scintillation detectors with caesium iodide
crystal (Figure 2.2). The crystal is 14 x 14 mm in size and is housed within a lead
collimator. Direct optical coupling between the crystal and large area photodiode
eliminates the need for bulky photomultipliers and shielding thus giving a small
lightweight detector which is easily attached to patients and is therefore relatively
user friendly in both the ward and Intensive Care setting.
2.1.2 Computer
A Cardstar portable PC (Portable and Upgrades Ltd, Stockport, U.K.)
order to accommodate an IBM PC compatible half-size card providing
of scaling and facilitate connection to the IBM bus.
2.2 RADIONUCLIDES
In these studies it was elected to use sodium pertechnetate (Technetium-99m)
(Amersham International Code NO INS IP) and Indium-111 (Amersham International
Code NO MCC 20). These radionuclides were chosen principally to facilitate the in




2.2.1 Labelling circulating transferrin
As albumin is quantitatively the major plasma protein many investigators have
chosen to label this protein. Early reports utilised albumin labelled with iodine-125
("'I) (Anderson et al. 1979) however iodine-125 has a half-life of 59.6 days and as
such would be unsuitable if repeated studies were to be contemplated. Much of the
earlier work in the U.K has utilised indium-113 (113In) which is no longer available.
As an alternative to "3In, both gallium-67 (67Ga) and indium-Ill (mIn) have been
used to label circulating transferrin.
67Ga is cyclotron produced, decays by electron capture and releases three different
gamma photons: 93 keV in 38% of it's disintegration's, 185 keV in 24% and 300
keV in 16 percent, the half-life is 3.2 days. 67Ga has been used by European
investigators in the determination of pulmonary microvascular permeability
(Raiijmakers et al. 1993, Raiijmakers et al. 1995). However concerns have been
raised regarding the efficiency of protein binding of 67Ga. In a similar manner to
'"In, 67Ga binds to the circulating plasma protein transferrin, although it does so less
avidly than '"In and may therefore dissociate from its protein bound state at a greater
rate throughout the study period. The dissociated molecules of 67Ga are then free to
diffuse into the interstitium of the lung and bind to transferrin already present from
leakage prior to the study period thus potentially giving rise to falsely high
recordings (Raiijmakers et al. 1992). In these studies we chose to employ "'In.
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Indium binds rapidly and efficiently with transferrin utilising the iron binding sites
on this protein. "'In chloride decays by electron capture and produces two energy
peaks: 171 and 245 keV. It may also be administered intravenously without the
requirement of withdrawing blood and handling blood samples. Disadvantages
compared to "3In include a half life of 2.8 days which results in a greater radiation
dose to the patient and as "'In is cyclotron produced, it is expensive and requires
advance ordering and preparation. Furthermore indium is taken up by the bone
marrow which would lead to high background readings on subsequent days and
possibly interfere with the interpretation of repeated studies. Nevertheless,
investigators in the Department of Nuclear Medicine and Intensive Care Unit,
Queens Medical Centre, Nottingham had been using Indium-Ill for the same
purpose and had reported initial promising results (Alan Perkins, Department of
Nuclear Medicine, Nottingham University, personal communication).
2.2.2 Labelling circulating erthrocytes
Technetium-99m (99mTc) has been used extensively as a label of erythrocytes. It
decays by isometric transition emitting a 140.5 keV gamma photon in 88% of its
disintegration's and has a half-life of 6.03 hours. It may be administered by
intravenous injection and when preceded by stannous pyrophosphate (see below)
approximately 40 - 50% of the injected dose is taken up by the skeleton within 3
hours. Up to 50% of the injected dose is cleared by urinary excretion within the first
3-6 hours. The activity retained on the erythrocytes remains unchanged from the
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time of injection to about 4 hours post injection when a slight decrease can occur
(Pavel etal. 1977)
Stannous Pyrophosphate (Pyroscint) Medgenix Code 2003002
Stannous pyrophosphate facilitates in vivo labelling of red blood cells by "mTc by
soaking them with stannous ions. It is administered intravenously at least 15 minutes
prior to the administration of technetium-99m.
2.3 RADIATION SAFETY
I attended the University of Edinburgh Radiation Protection Course June 1994. All
work involving the handling and administration of radioactive substances was carried
out under the guidance of Dr Malcolm Merrick, Consultant in Nuclear Medicine, Dr
Jim Hannon, Medical Physics Department, Western General Hospital and Dr Alistair
Millar, Radiopharmacy, Edinburgh Royal Infirmary.
Radionuclides were drawn up in a designated and supervised area. When handling
radioactive materials a laboratory coat, gloves and radiation film badge were worn.
Working behind a lead-glass shield, radionuclides were drawn into syringes over a
spill tray. The radioactive source was handled with tongs and the syringe containing
the radiopharmaceutical transported in lead syringe holders. Radiopharmaceuticals
were administered only by myself. The syringe and needle were disposed of in
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dedicated indium and technetium bins located in the Radiopharmacy Department of
the Edinburgh Royal Infirmary, the Nuclear Medicine Department, Western General
Hospital Trust and in Room 7, Rayne Laboratory, Edinburgh City Hospital.
2.4 SUBJECTS USED IN STUDIES
2.4.1 Healthy Volunteers
Healthy volunteers were required by the Administration of Radioactive Substances
Advisory Committee (ARSAC) to be over fifty years of age when studies involved
the administration of the indium-Ill radionuclide. Volunteers were recruited
through an advertisement in a local newspaper requesting assistance from non¬
smoking persons over this age. Respondents were sent a written explanation of the
project followed by a telephone call to ascertain if they wished to participate. Those
who wished to continue with the study were invited to attend the Royal Victoria
Chest Clinic, Chalmers Hospital and undergo a medical history, examination, chest
radiograph and spirometry. Volunteers were given a further verbal explanation of the
project and if agreeable to participate asked to sign the consent form. Following this
selection process eight healthy male volunteers, median age 59 years (range 51-66)
were enrolled. No patient had a history of recent or past respiratory illness and all
were non-smokers. Chest radiograph and spirometry were within normal limits.
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2.4.2 Patients with ARDS.
Patients with established ARDS were enrolled from the Intensive Care Unit at the
Western General Hospital Trust, Edinburgh, Scotland. ARDS was defined using the
American-European Consensus Statement (Bernard et al. 1994).
The lung injury score described by Murray and colleagues was used (Murray et al.
1988). The score is based on the systemic oxygenation, quantified as the Pa02/Fi02
ratio, and the appearance of the chest radiograph, the level of PEEP and when
measured the respiratory system compliance. Using this system, lung injury may be
quantified as mild to moderate (0.1 to < 2.5) or severe ( > 2.5).
2.4.3 Patients at-risk ofAcute Lung Injury and ARDS
A key element to this thesis was the study of patients who were predictably at-risk of
ARDS. Previous studies in Edinburgh recruited patients with multiple trauma,
perforated viscus and severe pancreatitis with a high rate of progression to ARDS
(Donnelly et al. 1993). However, the unpredictable nature of their presentation
presented logistic and technical problems for studies involving the use of indium-111
(luIn ). As mentioned, "'In is cyclotron produced and requires both advance
ordering and preparation by the radiopharmacy department, it is also expensive thus
it was likely that unless we enrolled patients from a predictable population , we
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would undoubtedly waste considerable quantities of 11'In. I therefore chose to study
patients undergoing oesophageal resection of malignant disease. During this
procedure one lung undergoes deflatation to allow access to the oesophagus and is
thereafter handled during the operation and at the end of surgery reinflated. Rapid
re-expansion is known to predispose to the development of pulmonary oedema
(Pavlin et al. 1981, Henderson et al. 1985). The contralateral lung therefore receives
the total ventilation and may be subject to barotrauma, also known to cause lung
injury (Gammon et al 1992). This model has been utilised in similar studies of
pulmonary permeability (Rocker et al. 1988 b). Patients undergoing
oesophagogastrectomy were enrolled from the Cardiothoracic Unit, City Hospital,
Edinburgh and The Western General Hospital Trust.
2.4.4 Ethics
All studies were approved by the Ethics Committee of the Lothian Health Board,
Scotland, (reference numbers 1702/94/1/18, 1702/94/1/20, 1702/94/3/21), the
management of each of the participating Hospital Trusts. Approval was also sought
from the Administration of Radioactive Substances Advisory Committee (ARSAC)
and the certificates were held by Dr Malcolm Merrick (reference numbers RPC 76-6
(62), RPC 76-6 (61) and RPC 162-26 (9)). Informed consent was obtained from each
subject, or in the case of a ventilated subject, the next of kin.
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2.5 STUDY PROCEDURES
2.5.1 Pulmonary Microvascular Permeability
(a) Protocol used for data acquisition.
Background counts were collected using 3 one minute counting periods. The
Compton scatter protocol utilised 4 one minute counting periods and the study
protocol utilised 180, 18 second counting periods to run for a total time of 54
minutes.
(b) Method of data collection
The Mediscint system was switched on 30 minutes prior to the study, at the end of
this time, background counts are collected (the protocol used is stated above).
Stannous pyrophosphate (0.4 mg/kg) was reconstituted in 10 ml of sodium chloride
and two 10 ml saline flushes were drawn up. 10 MBq of indium-Ill chloride was
drawn-up into a syringe and the acivity checked using a radionuclide calibrator
(Capintec CRC-15R Radionuclide calibrator, Ramsay, New Jersey, USA). The
syringe was then placed in a lead syringe holder before transport to the patient.
Following the collection of background counts, the reconstituted stannous
pyrophosphate injection was administered by slow intravenous injection directly into
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a large forearm vein (Millar AM et al. 1983). A butterfly needle was then sighted in
a large forearm vein and 10 MBq '"In administered, followed by a 10 ml saline
flush. The right lung probe was positioned over the mid-zone in the mid-clavicular
line and the left lung probe over the second interspace in the midclavicular line. The
heart probe was placed over the left ventricle (position ofmaximum count rate). The
probes were held in position by Mepore (Molnlycke, Sweden) and the Compton
Scatter protocol commenced (see above).
Following the Compton Scatter protocol lOMBq of 99m-sodium pertechnetate was
drawn into a syringe and the activity checked using a radionuclide calibrator
(Capintec CRC-15R Radionuclide calibrator, Ramsay, New Jersey, USA). The
syringe was transported to the patient in a lead syringe holder. No less than fifteen
minutes after the pyrophosphate injection and following the completion of the
Compton Scatter protocol, 10 MBq 99m-sodium pertechnetate was administered by
slow intravenous infusion followed by 10 ml of normal saline flush. A further ten
minutes were allowed for red cell labelling and mixing and the study protocol
commenced. The study was terminated after the data collection period was
completed.
Calculation of PAI from stored raw data.
The computer software stored the average count rate in counts per second (cps)
recorded over the count period specified in the protocol for each one of the six
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channels (2 channels per detector) simultaneously. Subsequent mathematical
manipulations could be carried out on the results from each counting period for each
detector.
Background correction:
Background counts were averaged for the three one minute counting periods
recorded at the start of the study. If the background count rate was greater than one
count per second the value recorded for that detector channel was subtracted from
each stored value for that detector before further data manipulation.
Derivation of Compton downscatter correction factor:
This facilitated a correction for the number of counts due to 11'In which appear in the
technetium window and would otherwise falsely elevate the apparent "mTc count
rate. Fifteen minutes after the injection of "'In count rates were recorded in both the
indium and technetium channels. The indium count which is measured in the
technetium window is divided by count rate recorded simultaneously in the indium
window. Four one minute counting periods were used and the average value
obtained over these counting periods was used to derive the scatter correction factor
for each detector.
Correction of the "mTc count data for Compton scatter during the study:
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The 11'In count rate for each period of the study was multiplied by the Compton
correction factor derived above and the value subtracted from the simultaneously
collected counts from each period in the "mTc channel thereby deriving the corrected
"mTc count rate.
Derivation of the U1ln and "mTc Lung/Heart (L/H) ratios:
For indium, the L/H ratio is obtained by dividing the counts recorded by the "'In
channel from the right and left lungs respectively by those counts simultaneously
recorded by the "'In channel over the heart. Using the corrected count rates for
technetium the "mTc is calculated in a similar manner.
Derivation of the extravascular "'In counts:
The "'In L/H ratio was divided by the "mTc L/H ratio for each study period.
Relationship of extravascular '"In counts to time and derivation of the PAI:
Each of the values derived above was plotted against time from the start of the data
collection.
The computer is used to plot a line of best fit to the above plot using the least squares
method and it is the slope of this line which is taken as the PAI (units of 10"3 per sec).
The result is then multiplied by sixty to convert the result to minutes. When both
lungs were studied the results from both lungs were averaged and recorded as the
protein accumulation index (PAI) with units 10"3/min. A schematic representation of




Venous blood was withdrawn from a peripheral vein or when available, a central
venous catheter. After sampling, blood was stored on ice until transport to the
laboratory. Blood samples were centrifuged at lOOOg x 10 minutes x 4°C, the
supernatant then aspirated and stored at -70°C.
Arterial blood:
Arterial blood was withdrawn from an indwelling arterial line into a heparinised
syringe and analysed immediately. Oxygenation was determined as the Fi02/Pa02
ratio derived from the circulating oxygen tension (kPa) and the inspired oxygen
fraction (%.10~2).
2.5.3 Enzyme Linked Immunosorbent Assays
Soluble L-selectin
The sL-selectin ELISA was performed as described (Spertini et al. 1992). Briefly 96
well microtitre plates (Costar, Cambridge, MA) were coated with anti-L-selectin
mAb (LAM 1.5 at 3pg/ml) and incubated overnight at 4°C. The wells were blocked
with 2% bovine serum albumin and 1% gelatin for 1 hour at 37°C and then washed
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with 0.1% Tween 20. Diluted patient serum was added (each sample is tested in
triplicate). Each assay included the titration of a previously quantified standard
plasma sample that was used to generate a standard dilution curve. After washing the
plates were incubated with biotinylated anti-LAM 3 MoAb (lpg/ml) for one hour at
room temperature. The plates were then washed and developed with o-
phenylenediamine (0.125% w/v, Sigma) as a substrate in 0.1 M citrate buffer, pH 4.5
in the presence of 0.015% H202. The optical density (OD) of the reaction mix was
quantified using a Dynatech MR5000 plate reader. Background OD values were
obtained using wells albumin coated. The sensitivity of the ELISA was greater than 5
ng/ml.
von Willebrand ELISA
Circulating von-Willebrand factor antigen (vWfiAg) was assayed by a double
antibody sandwich ELISA according to previously described methods (Bartlett et al.
1976). Ninety-six well plates (Costar, Cambridge, MA) were coated with rabbit anti-
human von-Willebrand factor (DAKO code A 082) at 5.4 mg/ml and incubated
overnight at room temperature. Unabsorbed solution was discarded and the plates
washed. Dilutions of the control (NIBSAC 5th British Standard) and samples were
applied in triplicate and the plates incubated for two hours at room temperature
following which time, peroxidase-conjugated rabbit anti-human von-Willebrand
factor was added (DAKO code P226-HRJP) and plates again incubated for two hours
at room temperature. The plates were developed with tetramethyl-benzidine
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Microwell Peroxidase Substrate (DYNATECH), the reaction stopped with 0.18 M
sulphuric acid and the developed plates read on a Dynatech MR5000 plate reader at
450 nm.
Elastase Radioimmunoassay
Human neutrophil elastase was measured by a specific radioimmunoassay (RIA)
with rabbit polyclonal antiserum according to the method (Bell et al. 1990). The
antigen was purified from human neutrophils after leucopheresis (Calbiochem,
Nottingham, UK). The antibody was specific for neutrophil elastase and did not
cross react with pancreatic elastase (Sigma) or neutrophil-free lysed human platelet
concentrate. The RIA used a 50pl standard/sample added to 50ptl of l25labelled
elastase (lOng/ml) and 50pl anti-elastase antibody diluted to 1:3000. After overnight
incubation at room temperature, donkey anti-rabbit immunoglobulin was added.
After shaking for 45 minutes at room temperature, bound complex was separated
from free complex by sedimentation through 10% sucrose at lg, aspirated and
counted in a NE 1600 gamma counter (Nuclear Enterprises, Edinburgh, UK). The




A commerically available ELISA kit was employed (Diagnostica Stago, via Shield
Diagnostics, Dundee, Tayside, U.K.). The epitopes on Tm recognised by these
antibodies have been described (Amiral et al. 1994).
ELISA's for E- and P-selectin.
The above were analysed using commercially available double-antibody sandwich
ELISA kits (Bender Medical Systems, Vienna, Austria)
Calculation of ELISA Results
ELISA results were analysed with the Assay Zap soft ware programme for
Macintosh computer (Biosoft Cambridge, UK) which uses a weighted four parameter
curve fit on log transformed data.. Sample concentrations were calculated by
interpolation of their mean absorbance on the standard curve.
2.6 STATISTICAL METHODS
Statistical analysis was performed on Macintosh computer using Abacus concepts
Statview II statistical package (Abacus Concepts, Inc., Berkeley, CA, 1987). Data
are expressed in the text as mean (SD). Non-parametric statistical analysis was
applied. Comparison between groups were made by Kruskal-wallis test and Mann-
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Whitney U test. Spearman rank was used to perform correlation's between PAI and
circulating mediators. Bonforoni correction was applied to correct for multiple ties.
The paired Students t-test was used to compare the PAI between the deflated and
ventilated lungs. A p value < 0.05 was accepted as statistically significant.
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Figure 2.1 The portable Mediscint system (Oakfield Instruments LTD, Oxford,
U.K.). Comprises an integrated system consisting of a Cardstar portable computer
(Portable and Upgrades Ltd, Stockport, U.K.) linked to miniature scintillation
counters (not shown in this photograph) through a multichannel analyser.
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Figure 2.2 The miniature scintillation counter (Oakfield Instruments LTD, Oxford,










The system was set-up with a lower energy window of 88 - 170 keV (to include the
photopeak and Compton scatter from 99raTc) and an upper window of 170 - 500 keV
(to include both photopeaks of "'In and as much possible of the Compton scattered
radiation) (Figure 3.1). These settings were chosen to maximise sensitivity to 11'In,
minimise positional sensitivity and facilitate the use of lower administered activities
of the radionuclide to reduce the radiation dose to the patient. Although there was a
cross-over from indium into the technetium windows it was possible to correct for
this when analysing the study data (see section 2.5.1) As it would not be possible to
correct cross-over of 99mTc into the upper window during studies sequential count
rates were recorded in both the technetium and indium windows from point source
of99mTc.
Method
The experiments were performed in a dedicated room in the Radiopharmacy
Department of Edinburgh Royal Infirmary. The Mediscint system was switched on
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and allowed to run for approximately 30 minutes prior to commencing the
experiment. A fixed point source of "mTc was placed in a water bath and the
distance from a miniature scintillation detector fixed to the external wall adjusted to
record similar count rates observed in patients. Simultaneous recordings were made
in both the technetium and indium windows.
Results and conclusion
The results are displayed in Table 3.1. It can be seen that the average cross-over of
"mTc into the upper window was less than one percent of detected counts, (mean =
0.73 %)
3.1.2 Dead Time
When a gamma ray strikes the scintillation material, the energy is transformed into a
flash of light. During the period in which the scintillation crystal is processing the
detected event, the equipment becomes refractory and consequently any gamma rays
which strike the crystal during this period will not be registered. The duration during
which a new event cannot be registered is termed dead time and is dependent upon
the crystal and the electronics of the machine. If the administered activity of
radionuclide gives rise to count rates which saturate the system significant dead-time
losses may occur which would lead to an underestimate of the true count rate. In
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order to ensure that the count rates detected in the patient groups would not be
influenced by dead-time losses, the dead time was assessed as follows:
Method
The experiment was set-up as previously described in section 3.1. A fixed point
source of "mTc, at a sufficient activity to saturate the system, was placed in a perspex
water-bath and a scintillation counter fixed in apposition to the external wall. The
technetium was then allowed to decay over a 24 hour period and the activity recorded
by the Mediscint system.
Results and conclusion
Figure 3.2 displays the count rate plotted against time. As count rates in the higher
part of the curve are more likely to be subject to dead time losses, count rates from
the lower part of the curve are used to calculate the dead-time of the equipment. I
arbitrarily selected to use count rates obtained from 18 hours onwards and plotted the
natural log of the count rate against time as shown in Figure 3.3. The extrapolation
of this line to the y axis gives the line of least squares fit to the data and represents
the natural log of the count rates expected to occur for the point source of 99m Tc
when no dead time losses are incurred. Taking the reciprocal of the natural log of the
expected count rates allows calculation of the actual expected count rate and this is
plotted, together with the observed count rates in Figure 3.4. It can be seen that at
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higher count rates the difference between the observed and expected count rate
increases reflecting greater dead time loss. The ratio of expected to observed counts
allows calculation of the correction factor required at any given count rate and this is
represented graphically in Figure 3.5. It can be seen that provided count rates are
kept below 10 000 counts/sec, no correction is required for dead time losses with the
Mediscint system.
3.1.3 Electrical Drift
The physical performance of a detector system may vary with the operating
temperature ("electrical drift"). To ensure that no significant electrical drift would
occur during the study period the following experiment was performed.
Method
The experiment was again set-up as described in section 3.1 A fixed point source of
"mTc (adjusted to avoid dead-time losses) was placed in a water bath at room
temperature. Counts were recorded over a two hour period.
Results and conclusion
90
Count rates from "mTc were corrected for decay and the corrected count rates
transformed to their natural log and plotted against time as shown in Figure 3. 6. It
can be seen that over a 1 hour study period, no significant electrical drift occurs and
thus is unlikely to be a factor in influencing results obtained from the system during
our study period.
3.1.4 Detector sensitivity as a function of position
To assess the relative sensitivity of the detector as a function of position within the
patient, a series of phantom experiments were performed in a water bath. The
activity of each source was adjusted to give a count rate below 5000 c/s and counts
for 99mTc were corrected for anticipated decay assuming a half-life of 6.03 hours.
(a) Angle and Depth
The scintillation detector was fixed in apposition to the external wall of the perspex
water bath, a point source of each radionuclide placed at increasing distances and
angles from the centre of the detector and the count rate recorded.
Results and conclusion
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Figure 3.7 demonstrates that for a point source of 11'In, the detected count rate falls
rapidly when the source is positioned at an angle of greater than 30° from the centre
of the miniature scintillation detector, suggesting that the volume of lung tissue
sampled will lie within this narrow cone. In vivo, systemic distribution of the isotope
will result in a broad beam rather than a point source rendering such an effect less
critical. In a similar manner, it can be seen from Figure 3.8 and 3.9 that as the
scintillation counter is unfocused, the detected count rate to a point source is
governed by the inverse square law and thus the detected count rate will be
influenced by the thickness of the underlying chest wall. Furthermore. Figure 3.10
demonstrates that at increasing distance from the detector, the higher energy '"In
(energy peaks at 171 and 245 keV) dominates detected count rates over the lower
energy "mTc (140.5 keV) implying that any alteration in the composition of the
underlying lung tissue during the study period, such as may occur if the detector is
repositioned, will alter the ratio of "'In to "mTc without the need for a change in
pulmonary microvascular permeability.
92
"mTc window '"In window % spill over into




Table 3.1 Count rate detected in the indium energy window of the Medisicint













171 2So" 245 Jo" 5J0
Energy
(keV)
Figure 3.1 Calibration of the Mediscint Dual Isotope system. The lower energy
window extends from 88 - 170 keV (to include the photopeak and compton scatter from
99mxc) and the upper from 170 - 500 keV (to include both photopeaks of 11 Un and as
much of the compton scatter radiation as possible).
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Figure 3.2 Graph of count rate observed by the Mediscint system from a point sourceo^^c at
an initial energy sufficent energy to saturate the system . The point source was placed in a waterbath
and count rates were recorded continuously over time.
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Figure 3.3 Graph of the natural log (ln) of the observed count rate plotted against time. Only the last
8 hours of the observed count rate are selected and the line of best fit is extrapolated to its intercept














Figure 3.4 Graph of observed and expected count rates plotted aganst time. It can be seen that at higher


















Figure 3.5 Graph of correction factor plotted against observed count rate. It can be seen that for









Figure 3.6 . Natural Log of corrected count rate from a point source o^^mTc plotted
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Figure 3.7 Relative Count Rates at differing angles from the detector from a point
source of* * *In. It can be seen that the detected count rate rapidly falls
as the point source is positioned at an angle of greater than 30c
from the detector
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FIGURE 3.8 Percentage count rates detected from point source of indium which has been placed
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FIGURE 3.9 Percentage count rates detected from a point source of technetium which has been
placed in a water bath at placed at increasing distances from a miniature scintillation detector.
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FIGURE 3.10 Ratio of In/Tc counts recorded from point sources of each isotope in a water bath.
It can be seen that with increasing distance from the detector the higher energyidium dominates




As discussed in the introductory chapter, the measurement of pulmonary
permeability is likely to be of benefit in both the diagnosis and management of
patients with ARDS. In this study I wished to employ the portable Mediscint system
in the setting of a busy Intensive Therapy Unit to record pulmonary microvascular
permeability readings from patients with established acute respiratory distress
syndrome. In addition, I wished to determine whether any relationship existed
between the degree of pulmonary permeability recorded and other concomitantly
displayed physiological parameters of gas exchange and circulating parameters of
inflammatory cell and endothelial activation/damage which might be more easily
measured in a greater number of patients and therefore applicable to multicentre
studies.
4.2 PATIENT CHARACTERISTICS
A control group of eight helathy male volunteers was enrolled, median age 59 years
(range 51-66). No patient in the control group had a history of recent or past
respiratory illness and all were non-smokers. Chest radiograph and spirometry were
within normal limits (Table 4.1). Twelve patients with ARDS were identified using
the criteria of the American-European consensus statement (Table 4.2) and enrolled
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in the study. Five patients were male, the median age was 71 years (range 49 - 83)
and the median duration ofARDS was 6 days (range 1-15).
The median PAI for patients with established ARDS was 0.42 x 10"3/min (range -0.77
to 1.48 x 10-3/min) compared to median value of -0.5 x 10-3/min (range -1.73 to
0.27 x 10-3/min) for the control group (Figure 4.1). There was no difference
between the right and left lungs for both the control (Figure 4.2) and ARDS patient
group (Figure 4.3) but the degree of correlation between both lungs was less good
for the group of patients with ARDS with r = 0.504 compared to the correlation
between right and left lungs of the normal volunteers with r = 0.84.
The median Pa02/Fi02 ratio was 21.9. (range 12.55 to 37.42). The median lung injury
score was 3.25 (range 2.5 to 4.0).
Values for circulating markers were as follows. For the control group of healthy
volunteers the circulating neutrophil elastase was 12.95ng/ml (range 8.4 to 19 ng/ml),
thrombomodulin 24.7 ng/ml (range 3 to 47 ng/ml), vWf:Ag 1.03 IU (0.8 to 1.7 IU), sE-
selectin 29.0 ng/ml (range 13.2 to 91 ng/ml), sP-selectin 150.5 ng/ml (range 78 to
263 ng/ml), sL-selectin 2.88 ng/ml (range 1.5 to 3.4 ng/ml).
For patients with ARDS the median and range for neutrophil elastase was 94.0 ng/ml
(range 29 to 420 ng/ml), for thrombomodulin was 44.0 ng/ml (range 13.4 to 90.0
ng/ml), for vWf:Ag was 2.38 IU (range 0.75 to 4.80 IU), for sE-selectin was 75.0
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(range 46 to 162 ng/ml), for sP-selectin was 92.0 ng/ml (range 40 to 118 ng/ml) and
for sL-selectin 2.03 ng/ml (range 0.81 to 3.45). Compared to the control group,
significantly altered levels of circulating Tm, vWf:Ag, neutrophil elastase, sE- and
sP-selectin were observed (Table 4.3).
There was no relationship between the PAI and the gas exchange, lung injury score
and any of the markers of neutrophil activation or endothelial activation/damage
(Table 4.4).
4.3 SUMMARY OF RESULTS
This study showed greater pulmonary microvascular permeability in patients with
established ARDS as compared to the control group. However considerable overlap
occurs between the two groups and accordingly there was no statistical significant
difference between patients with ARDS and the control group. There is no statistical
difference between the PAI for each lung in both patient groups but the correlation
between the right and left lungs is less good for patients with ARDS. No relationship




Increased pulmonary microvascular permeability is believed to represent a
fundamental pathophysiological event in the ARDS disease process and previous
studies using a similar technique have demonstrated significant elevations in the
protein accumulation index of patients with ARDS (Basran GS et al. 1985, Braude S
et al. 1986, Rocker et al. 1988 (a)). Reasons for the limited elevation observed in this
study may relate to the time point in the natural history of the disease at which the
studies were performed or limitations in the recording system.
Previous studies were performed on patients following admission to the Intensive
Care Unit and as soon as the diagnostic criteria for ARDS were fulfilled and thus it is
likely that patients studied were in the exudative phase of the disease process. In this
study the majority of patients were suffering from established disease with a median
duration of 3 days (range 1, 15 days). Although it has been suggested that
pulmonary microvascular permeability is elevated throughout the course of the
ARDS disease process (Sinclair et al. 1994), histological examination of tissue
obtained from patients with ARDS suggests that the condition evolves through an
exudative phase of oedema and haemorrhage, a proliferative phase of organisation
and repair and a fibrotic phase of end-stage fibrosis (Tomashefski et al. 1990, Hill et
al. 1976). The pathology of established ARDS is characterised by the proliferation of
fibroblasts and the deposition of new connective tissue matrix resulting in areas of
damaged and scarred lung were protein leakage is not a dominant feature (Bachofen
and Weibel. 1982). None of our patients underwent open lung biopsy but we might
reasonably hypothesise that the majority of patients had made the transition from the
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early exudative stage and would not necessarily be expected to display large
increases in microvascular permeability. Both Braude and Rocker performed their
studies on patients on admission to the Intensive Care Unit and as soon as the
diagnostic criteria for ARDS were fulfilled and would thus have studied patients in
the early and exudative stage of the disease. However, even at this time point both
investigators recorded permeability indices in some ARDS patients within the normal
range suggesting that there may be patients in whom ARDS may arise in the absence
of any increase in pulmonary microvascular permeability, or that the phase of
enhanced permeability was of short duration and had ceased before these
measurements were taken.
In view of previous studies using similar equipment (Sinclair et al. 1994) and a PET
scanning technique (Velaquez et al. 1991) demonstrating a relationship between the
degree of lung leak and markers indicative of the severity of lung damage, it is
disappointing that no such relationship was observed in this study. Pulmonary
microvascular permeability recorded by a dual isotope system similar to that used in
this thesis demonstrated a correlation between the protein accumulation index and
both the lung injury score and the degree of neutrophilia on bronchoalveolar lavage
in 14 patients with ARDS (Sinclair et al. 1994). In a dog model of inflammatory
lung injury, regional pulmonary permeability assessed with a PET scanner could be
correlated with the structural abnormality observed in the alveoli under both light and
electron microscopy (Velaquez et al. 1991).
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The use of miniature scintillation counters depends on the assumption that
abnormalities of pulmonary permeability are homogeneously distributed throughout
the lung and thus it will be possible to extrapolate from measurements made on a
small volume of lung tissue to events occurring in the entire lung (Gorin et al. 1980).
However the use of CT scanning has clearly demonstrated that in contrast to
appearances on the chest radiograph, the distribution of the ARDS is far from
homogenous. A study of 13 patients with ARDS, 11 patients in whom the chest
radiograph demonstrated homogenous disease, CT examination revealed a patchy
involvement with areas of relatively normal lung interspersed between patches of
densely consolidated and collapsed lung (Maunder et al. 1986). This may be
supported in these studies by finding that the degree of correlation between the right
and left lung is less good for the patient group suffering from ARDS than the normal
volunteers.
The use of a portable system with miniature scintillation probes instead of a gamma
camera, whilst convenient, may give rise to sampling errors. In patients who had
undergone re-expansion of lung during treatment for pleural effusion or
pneumothorax, large sodium-iodide scintillation probes positioned over the area of
presumed maximum re-expansion (as judged by the chest radiograph) compared to
simultaneous data acquisition from a gamma camera, demonstrated that the probe
system reported an erroneously low reading in just under one-third of patients. This
was attributed to problems positioning the probe over the site ofmaximum increased
permeability as detected by the gamma camera (Keegan et al. 1989).
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Previous investigators have used the larger sodium-iodide detectors which although
are both bulky and heavy, have the advantage that they may be focused to sample a
greater depth of lung tissue (Gorin et al. 1981, Rocker et al 1988 (a) Rocker et al
1988 (b), Rocker et al 1989). The mediscint scintillation counter is essentially
unfocused and as demonstrated in chapter three, is likely to sample only a limited
volume of lung tissue which is unlikely to be representative of the ARDS disease
process in the lung as a whole. Thus indicators ofmore generalised function such as
gas exchange and lung injury score would be less likely to display a relationship with
the PAI recorded by this technique. Similarly this may explain a lack of relationship
with markers of endothelial damage.
These limitations may be obviated by use of regional imaging with a gamma camera,
but this would result in the inconvenience of gamma camera recordings in the
intensive care unit coupled with the requirement for larger doses of radioactivity. In
considering future studies with these, or similar, miniature scintillation detectors,
multiple recordings from the lung fields should be considered with investigators
making recordings on the lateral and posterior chest walls. Given that the
reticuloendothelial system is involved in clearing the labelled red cells it would be
necessary to avoid counting over the liver and spleen and care must be taken with the
left lung probe to avoid counting over the heart and major blood vessels. Centres
with access to PET scanners may be better placed to answer the questions of this
study.
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A further factor to explain the lack of relationship with indices of lung injury may be
attributed to the power of the study, given low patient numbers, to detect such a
relationship. Accepting a power of p < 0.1 would demonstrate a relationship between
the LIS and the PAI.
The factors discussed above may also explain the lack of relationship observed
between the PAI and circulating markers of neutrophil activation or endothelial
activation/damage, however, for future studies it should be considered whether other
markers may be more appropriate. Given that pathological studies in ARDS often
show greater epithelial than endothelial damage it may be helpful for future
investigations to explore the relationship between the degree of pulmonary
permeability and markers which specifically reflect epithelial damage. It is now
possible to measure the serum concentration of surfactant protein A (SP-A), the
major surfactant protein produced by type II pulmonary epithelial cells (Doyle et al.
1994) and recent work has begun to characterise markers of type I epithelial cell
damage in animals (Dobbs et al. 1988, McElroy et al. 1995).
Circulating concentrations of SP-A have been examined in the sera from 15 patients
with ARDS, 10 patients with acute cardiogenic pulmonary oedema, 6 ventilated
patients with no cardiorespiratory disease and 15 healthy subjects. Significantly
elevated levels were reported in the ARDS group and were found to correlate
inversely with the static respiratory compliance and systemic oxygenation of the
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patients. The investigators speculate that this finding may reflect abnormal alveolar-
capillary permeability (Doyle et al 1995). Using an animal model of lung injury,
Dobbs and colleagues have identified a specific 40- to 42- kDa protein (rTI40) located
on the apical surface of rat type I pulmonary epithelial cells (Dobbs et al. 1988)
which may be detected in the BAL fluid following the administration of
Pseudomonas aeruginosa. The group have demonstrated that elevated levels of rTI40
reflect both the severity of injury to type I cells but also the degree of impairment to
the alveolar-capillary barrier function (McElroy et al. 1995).
In conclusion, the PAI in patients with established ARDS in this study was
marginally greater than that of a control group but considerable crossover occurred
between groups and consequently no statistical significant difference was noted.
This may be due to the selection of patients in the later stages of the disease process
in which lung leak may not be a major component of on-going lung injury. No
relationship was observed between the recorded pulmonary microvascular
permeability and physiological or circulating markers. Although this may reflect the
limited volume of lung sampled by the miniature scintillation detector and the power
of the study with limited patient numbers it should be considered that other
circulating markers which reflect injury to the pulmonary epithelial surface may
prove more relevant as direct or surrogate markers of alveolar-capillary permeability.
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Volunteer Age Sex Chest PAI PAI PAI
Radiograph Right lung Left lung Average
(x 10 3/min) (x 10 3/min) (x 10 3/min)
1 51 M normal 0.06 -0.50 0.28
2 66 M normal -1.68 -1.78 -1.73
3 55 M normal 0.60 -0.05 -0.28
4 52 M normal 0.3 1.18 0.74
5 60 M normal -0.44 -0.42 -0.43
6 65 M normal 0.80 0.90 0.70
7 62 M normal -0.11 -0.43 -0.27
8 58 M normal -0.10 -0.02 -0.06
Table 4.1 Characteristics of healthy volunteers. All volunteers were non-smokers










































































































































Table4.2Characteristicofpatientgroupen oll dw thARDS.
Controls ARDS p value
Median (range) Median (range)
Elastase 12.95 (8.4 to 19) 94.0 (29 to 420) 0.01
Thrombomodulin 24.7 (3 to 47) 44.0 (13.4 to 90.0) 0.03
vWf:Ag 1.03 (0.8 to 1.7) 2.38 (0.75 to 4.8) 0.03
sL-selectin 2.88 (1.5 to 3.4) 2.03 (0.81 to 3.45) ns
sE-selectin 29 (13.2 to 91) 75.0 (46 to 162) 0.02
sP-selectin 150.5 (78 to 263) 92.0 (40 to 118) 0.01
Table 4.3 Circulating levels of plasma elastase (ng/ml), thrombomodulin (ng/ml),















Table 4.4 Relationship between the protein accumulation index (PAI) and the indices
of gas exchange and circulating levels ofplasma elastase (ng/ml), thrombomodulin











Figure4.1Proteinaccumulatioindi es( AI)ofhealthym lvolunte rs,mean(SD)--0.11(0.75)x10"3/ inandpatientswithARDS, (SD)=0.29(0.67)x1 'Vmin.Thereisnostatisticald fferencebetw enthwogroups
PATIENTS AT-RISK OF ARDS
5.1 INTRODUCTION
As discussed in chapter one, the earliest pathophysiological event in the genesis of
ALI/ARDS is extensive microvascular injury believed to be consequent upon an
exuberant local inflammatory response in which adherent activated inflammatory
cells (principally neutrophils) degranulate into a protected microenvironment,
facilitating unopposed degradation of the delicate pulmonary endothelium. The leak
of a protein rich fluid from the capillaries into the pulmonary interstitium and
alveolar airspaces may be charted in a non-invasive manner utilising radiolabelled
proteins and externally situated scintillation detectors. In chapter 4, studies utilising
the portable Medisicint system in patients with established ARDS were described.
However, for various reasons including the limited volume of lung sampled by the
miniature scintillation detectors, it was concluded that the technique is unlikely to be
suitable in patients with established ARDS in whom the disease process may be
heterogeneous. In this chapter the use of the Mediscint system was investigated in
patients earlier in the disease process, in whom the disease process may more
homogenous.
The aim of this study was therefore to assess the use of the Mediscint system in
patients at-risk of ALI/ARDS and again to determine if any relationship existed
between such measurement and physiological or circulating markers of alveolar-
capillary injury. I hypothesised that since the earliest events in the pathogenesis of
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acute lung injury syndromes are predominantly neutrophil mediated and occur in the
intravascular space, the most likely candidates for suitable markers reflecting an
increase in pulmonary microvascular permeability would result from neutrophil
activation and/or endothelial activation/injury. Markers particularly chosen for
analysis were neutrophil elastase, sL-, sE- and sP-selectin, thrombomodulin and von-
Willebrand factor antigen.
5.2 PATIENT CHARACTERISTICS
The control group have been documented in chapter 4. Twenty patients undergoing
oesophagogastrectomy for malignant disease were enrolled, 15 male. All patients
had a normal pre-operative chest radiograph. The characteristics of the post-
oesophagogastrectomy patients are summarised in Table 5.1. The median age as
65.5 years (range 52, 79). Seventeen patients underwent thoracic resection via a left
thoracotomy and three patients right thoracotomy and abdominal resection. The
pulmonary microvascular permeability scans were carried out within six hours of the
procedure. Prior to commencing the study the patients underwent a post-operative
chest radiograph. The control group of healthy volunteers have been detailed in
chapter 4.2.
The median post-operative Pa02/Fi02 ratio performed at the termination of the scan
was 43.7 (range 23 to 75.8). The chest radiograph demonstrated minor atelectasis in
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4 patients and small pleural effusion in 2 patients but no patient displayed bilateral
diffuse shadowing consistent with acute lung injury.
The median PAI for the healthy male volunteers was -0.5 x 10-3/min (range -1.73 to
0.27 x 10-3/min). The median PAI for patients post-oesophagogastrectomy was -
0.005 x 10-3/min (range -1.53 to 2.28 x 10-3/min). There was no significant
difference between these two groups (Figure 5.1). There was no significant
difference in the PAI recorded from the lung ventilated during
oesophagogastrectomy and the lung which was deflated (Figure 5.2).
The circulating markers post-oesophagogastrectomy were as follows. The median
values of the circulating neutrophil elastase was 63.8 ng/ml (range 37 to 123 ng/ml),
of thrombomodulin was 37.0 ng/ml (range 9.6 to 52 ng/ml), vWf:Ag 3.4 IU (range
1.3 to 6.2 IU), of sE-selectin was 74.5 ng/ml (41 - 105 ng/ml), sP-selectin 229
ng/ml (range 129 to 343 ng/ml) and sL-selectin 1.96 ng/ml (range 0.8 to 4.6 ng/ml).
A significant difference was seen between the control group and the post-
oesophagogastrectomy group for the circulating plasma elastase, Tm, vWf:Ag, sE-
and sP- selectin but there was no difference between the levels of sL-selectin (Table
5.2).
A significant relationship was observed between the PAI and the Pa02/Fi02 ratio ( p =
0.04, r = - 0.46)(Figure 5.3) and the circulating plasma elastase (p = 0.04, r = 0.49 )
(Figure 5.4). However there was no relationship between the PAI and the circulating
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elastase in the normal volunteers. There was no relationship between the PAI and
any of the other circulating markers assayed in the normal volunteers or patient
group.(Table 5.3).
Patient numbers 1 and 9 developed persisting post-operative lung injury. Patient
number 1 developed bilateral diffuse radiographic infiltrates on subsequent PA chest
radiographs and a Pa02/Fi02 ratio of 16.9, 26.75 and 21.25 on the subsequent three
post-operative days, fulfilling the American-European Consensus diagnostic criteria
for both ALI and ARDS, before beginning to improve. He did not require
ventilation. Patient number 9 could not be weaned from the ventilator and developed
bilateral radiographic shadowing with Pa02/Fi02 ratios of 17.14, 12 and 22.8 again
fulfilling the American-European Consensus diagnostic criteria for ARDS.
Pulmonary capillary wedge pressure recorded on the fourth post-operative day was
22 mmHg. Patient number 4 suffered a collapse of the left lung 72 hours post¬
operatively and required suction with rigid bronchoscopy. Patient number 15 was
thought to undergo aspiration on the second post-operative day. The remaining
patients made uneventful recovery.
5.3 SUMMARY OF RESULTS
There is a trend towards elevation of the PAI in patients who have undergone
oesophagogastrectomy compared to the control group but this does not attain
statistical significance. Several of the studies display a negative value of PAI.
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Significant differences are observed between the control group and patients post-
oesophagogastrectomy for circulating plasma elastase, Tm, vWf:Ag, sE- and sP-
selectin. A statistically significant relationship is demonstrated between the PAI and
the Pa02/Fi02 ratio and the circulating plasma elastase however the relationship with
elastase does not hold true when one considers the normal volunteer group.
5.4 DISCUSSION
Oesophagogastrectomy is a recognised palliative procedure for malignant disease of
the oesophagus and cardia of the stomach. The procedure is safe with an acceptable
morbidity and mortality (Sabanathan et al 1996). The majority of early deaths relate
to the post-operative development of respiratory failure the causes of which are
multifactorial and include infection, aspiration, a systemic inflammatory response
and in some cases ALI/ARDS. Oesophagogastrectomy has previously been shown to
cause an elevation in pulmonary microvascular permeability (Rocker et al. 1988 (b) )
but the relationship between this and a range of physiological and inflammatory
parameters has not been compared.
In this study only 5 patients developed a PAI which was greater than 1 SD above that
of a control group and only 2 patients who developed an elevation in PAI greater
than 2 SD. The majority of patients maintained a PAI comparable to that of the
healthy volunteers and consequently there was no statistical difference between the
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two groups. Only two patients progressed to develop ARDS. Patient number 1
although having a clear chest radiograph at the time of recording a PAI of 2.28 x 10"
3/min (ventilated lung 2.22 and deflated lung 2.34) on the following 3 post-operative
days developed bilateral infiltrates on anteroposterior chest radiographs and fulfilled
the American-European consensus criteria for ARDS. The patient did not require
ventilation and a pulmonary artery wedge pressure was not recorded, although there
were no other clinical signs of left atrial hypertension. Patient number one also
recorded the lowest level of sL-selectin at 0.8 ng/ml and a high circulating elastase at
73.5 ng/ml. Patient number nine, with a PAI of 0.1 x 10-3/min (ventilated lung 0.7,
deflated lung -0.5), which fell within the normal range displayed by the control
group, was unable to be weaned from the ventilator, rapidly developing bilateral
infiltrates on anteroposterior chest radiographs and impaired systemic oxygenation
consistent with a diagnosis ofARDS. The pulmonary artery wedge pressure was not
recorded until the fourth post-operative day and was elevated at 22 mmHg, however
for reasons we have discussed in chapter 1, this does not necessarily imply the
clinical picture is secondary to cardiogenic oedema. Patient number nine also
displayed the highest levels of circulating elastase at 101 ng/ml and a low sL-selectin
of 1.18 ng/ml. In contrast, patient number 20, with a PAI of 1.9 x 10-3/min made an
uncomplicated recovery. The circulating elastase in patient number 20 was elevated
at 84 ng/ml as was the sL-selectin was marginally elevated at 2.28 ng/ml. Thus the
protein accumulation index, per se, as measured by this system is unable to predict
progression to ARDS. However there does appear to be a relationship between the
post-operative Pa02/Fi02 ratio and the PAI which suggests that the degree of
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endothelial permeability is a component of the early post-operative changes observed
in gas exchange.
Although there has been some speculation that an index of pulmonary endothelial
permeability may be helpful in predicting progression to ARDS (Braude S et al
1992), this may be considered overly optimistic. The pulmonary epithelial barrier is
recognised to represent the rate limiting step preventing alveolar oedema
(Schneeberger EE 1979) and, primarily via a sodium transport pump, is responsible
for reabsorption of any flooding which does occur (Mason et al. 1982, Matthay and
Weiner-Kronish. 1990). Furthermore animal models of acute lung injury have
demonstrated recovery of both the endothelial and epithelial barriers within several
hours of an antecedent precipitant to a level sufficient to facilitate reabsorption of
alveolar fluid (Wiener-Kronish et al 1991, Wiener-Kronish et al 1993, Pittet et al.
1995). Thus transient increases in permeability, as seen in patient 20, may represent
a forme fruste rather than a forerunner of inflammatory injury.
The limited role of the endothelial barrier is also supported in clinical studies where
endothelial markers have so far failed to identify those patients who may
subsequently progress to ARDS. Although one study of patients with non-
pulmonary sepsis found that an elevated plasma level of vWTAg had the potential to
identify patients who would subsequently progress to ARDS (Rubin et al. 1990), this
has not been borne out by further studies on more diverse patient groups (Moss et al.
1995, Sabharwal et al. 1995), although it is possible that the pathogenesis of lung
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injury may differ according to the antecedent precipitant (Moss et al 1996). In
addition, we have also found circulating levels of E- and P-selectin and Tm to be
unhelpful (Donnelly et al. 1994, Reid PT et al. 1995 (a)).
Attempts to identify a circulating marker to represent a surrogate for pulmonary
permeability continue to prove elusive. In this study a statistically significant
correlation was observed between the pulmonary microvascular permeability
recorded by the Mediscint system and the circulating neutrophil elastase in the post-
oesophagogastrectomy patient group. However, this relationship does not hold within
the group of normal volunteers. Further larger studies will be required to clarify
whether this relationship may prove to be valid. One previous study including a
more diverse patient group found a relationship between the PAI as measured by a
similar dual isotope technique and both the circulating and free elastase in the BAL
(Rocker et al. 1989) and in a study of fourteen patients with ARDS a relationship was
observed between the PAI and the BAL neutrophil count (Sinlcair et al. 1994).
Furthermore, our group has recently demonstrated that the initial plasma elastase,
taken in the resuscitation room of patients suffering multiple trauma may assist in the
identification of those patients who subsequently progress to ARDS (Donnelly et al.
1995). Nevertheless, the plasma elastase level in the post-oesophagogastrectomy
group only accounts for 25% of the variability and other factors undoubtedly
influence endothelial permeability including other neutrophil serine proteases such as
cathepsin G (Peterson. 1988) and free radicals such as hydrogen peroxide and nitric
oxide (Zhao et al. 1998, Okayama et al. 1997).
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The post-operative levels of the endothelial markers were significantly elevated
consistent with endothelial activation and/or damage but again no relationship was
demonstrated between these markers and the pulmonary microvascular permeability
recorded by our system. Before discounting any possible relationship it is perhaps
worth speculating that the choice of patient group was inappropriate to detect such a
relationship. Surgical resection of the oesophageal malignancy and fashioning of the
oesophagogastric anastomosis may result in elevation of endothelial markers per se,
in addition to those which may be released from the pulmonary circulation, which
could mask any relationship which may exist between these markers and the PAI. In
order to clarify this endothelial markers which are specific to either the pulmonary or
systemic circulation would be required. Of the currently available endothelial
markers, both vWf:Ag and sP-selectin are not only expressed throughout the
endothelial surfaces of the body but are also released from platelets (Sporn et al.
1985, Hsu-Lin et al. 1984, McEver et al. 1989). E-selectin and Tm appear to be
specific for the endothelium, but are widely distributed throughout the endothelium
of the body (Newman et al. 1993, Maruyama et al. 1985).
Finally one must speculate that this patient group may also act to confound the
measurement ofPAI itself. In these studies many patients displayed a negative value
for the PAI post-oesophagogastrectomy. Negative values have been recorded by
previous investigators using different isotopes and have been observed in studies by
other investigators (Basran et al 1985, Rocker et al 1987, Rocker et al 1988a).
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Negative values can potentially arise from inefficient binding of the 99mTc to the red
blood cells. This is an unlikely reason in these studies as a minimum of fifteen
minutes was allowed from the administration of the stannous agent to the
administration of the "mTc. The most likely explanation in these studies is that the
fashioning of the oesophagogastric anastomosis results in an inflammatory response
with an associated microvascular leak which is detected by the heart probe. This
explanation is supported by examining the slope of the heart indium trace. Examples
of post-oesophagogastrectomy patients in which a positive slope is observed are
shown (figures 5.5 - 5.8). Figures 5.9 and 5.10 provide examples of the curves
obtained from normal volunteers and figures 5.11 - 5.14 examples of curves obtained
from patients with ARDS. Furthermore the median slope index for heart indium in
normal volunteers is -0.48 x 10"3/min (range -1.8 to 1.0), for patients with ARDS is -
3.3 x 10"3/min (range -2.93 to -1.02) but for patients post-oesophagogastrectomy is -
0.17 x 10"3/min (range -4.4 to 3.92). Although this patient group has been studied
before without this apparent difficulty this may reflect the fact that a focused
collimator was used (Rocker et al 1998 b) in contrast to the unfocused collimator in
this equipment. Furthermore, we had increased the window settings to maximise
count rates from '"In and as much of the Compton scattered radiation as possible
(Chapter 3.1.1) which may have contributed to this phenomenon. In order to correct
for this in future studies it should be possible to modify the protocol. In studies from
the Netherlands determination of the circulating radionuclide activity was made by
serial venous blood sampling throughout the study period (Raiijmakers et al 1993,
Raiijmakers et al 1995). Whilst this has the disadvantage of requiring repeated
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transport of radioactive blood from the patient to a suitable radionuclide calibrator, it
eliminates any potential error arising from the collection of additional count rates by
the heart probe. This is of further importance when one considers patients
undergoing cardiopulmonary bypass provide an attractive model for studies
(MacNaughton et al. 1992). It is very likely that the median sternotomy and any
associated procedures such as harvesting of the internal mammary artery would give
rise to similar problems.
In conclusion patients post-oesophagogastrectomy develop a moderate inflammatory
response and a limited number display a modest elevation in pulmonary endothelial
permeability but this does not in itself appear to predict progression to acute lung
injury although it does demonstrate correlation with the post-operative gas-exchange
suggesting that early post-operative abnormalities in gas exchange may be due to
enhanced endothelial permeability. A convincing surrogate marker for pulmonary






































































































































































































median (range) p value
Elastase 12.95 (8.4 to 19) 63.8 (37 to 123) <0.01
Thrombomodulin 24.7 (3 to 47) 37 (9.6 to 52) 0.04
vWf:Ag 1.03 (0.8 to 1.7) 3.4(1.3 to 6.2) 0.01
sL-selectin 2.88 (1.5 to 3.4) 1.96 (0.8 to 4.6) ns
sE-selectin 29(13.2 to 91) 74.5 (41 - 105) 0.03
sP-selectin 150.5 (78 to 263) 229(129 to 343) 0.02
Table 5.2 Circulating levels of plasma elastase (ng/ml), thrombomodulin (ng/ml),






















Table 5.3 Relationship between the protein accumulation index measured by the
Mediscint system and circulating levels of thrombomodulin (ng/ml), vWf:Ag (IU),






























Figure 5.3 Relationship between the Pa02/Fi02 ratio and the protein accumulation index (PAI)









Figure 5.4 . Relationship between the the protein accumulation index (PAI) and the circulating
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Figure 5.5 Graph of recordings from post-oesophagogastrectomy patient number 1. The
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igure 5.6 Graph of recordings from post-oesophagogastrectomy patient number 5. The
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Figure 5.7 Graph of recordings from post-oesophagogastrectomy patient number 11. The























Figure 5.8 Graphs recorded from post-oesophagogastrectomy patient number 20. The
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Figure 5.9 Graphs recorded from healthy volunteer number 1. The PAI = 0.06 x 10-3/min




















Figure 5.10 Graphs of recordings from healthy volunteer number 3. The PAI = 0.6 x 10-3/min
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Figure 5.11 Graph of recording from patient number 1 with ARDS. The PAI= -0.7 x 10-3/min
and the heart indium trace displays a slope of -0.5 x 10-3/min.
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Figure 5.12 Graph of recordings from patient number 6 with ARDS. The PAI = 1.45 x 10-3/min
and the slope of die heart indium curve is -3.0 x 10-3/min.
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'igure 5.13 Graph of recordings from patient number 9 with ARDS. The PAI = -0.8 x 10-3/min


























Figure 5.14 Graph of recordings from patient number 12 with ARDS. The PAI = 1.0 x 10-3/min
and the slope of the heart indium is -2.9 x 10-3/min.
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CHAPTER SIX SUMMARY
Despite improvements in the delivery of critical and intensive care only marginal
impact has been made on the mortality and morbidity associated with ARDS and as
yet, no pharmacological intervention has been demonstrated to have a substantial
impact on the disease process. In part, this is likely to reflect the fact that using
current diagnostic criteria, extensive and catastrophic lung damage has occurred by
the time the physician can confidently diagnose the patient as suffering from ARDS.
The lung is then so severely injured as to render the process of repair and
remodelling an overwhelming task. From this perspective, we may reasonably
consider that further improvements in the outlook for patients with ARDS are most
likely to come from the earlier recognition of evolving acute inflammatory response.
Studies performed in Edinburgh, on the bronchoalveolar lavage and blood from
patients suffering known precipitants of lung injury but who are within the earliest
stages of the risk period, have demonstrated that it is potentially possible to identify
those patients who are at highest risk of proceeding to established lung injury
syndromes. However, bronchoalveolar lavage may be difficult to perform early in
the at-risk period and the preparation and processing of the samples including the
performance of enzyme-linked and radioimmunoassyas involved may take hours to
days before the results may be available.
The application of measurements of pulmonary microvascular permeability are
attractive for several reasons. Pathological studies suggest that the earliest events in
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the pathogenesis of ARDS occur within the pulmonary microvasculature with a
resultant breakdown in the alveolar-capillary barrier function. Furthermore,
enhanced pulmonary microvascular permeability is central to our understanding of
the pathophysiology of established ARDS and was recognised by the American-
European Consensus statement as an important area in which to direct further
research.
In this thesis I have evaluated the use of a fully portable dual system which utilises
miniature scintillation counters and provides a non-invasive method of pulmonary
microvascular permeability based on charting the transit of radiolabelled proteins. I
have shown from phantom experiments that the system is capable of recording from
both indium and technetium radioisotopes simultaneously in the setting of the
Intensive Therapy Unit but that the miniature scintillation counters are likely to
sample only a limited volume of lung tissue in any given patient. This is an
important finding as the principle of the technique depends on the extrapolation of
data obtained by recording over a small area of lung tissue to make an inference on
the function of the lung as a whole. Whilst this may be applicable in disease
processes which are homogeneously distributed throughout the lung, we are now
aware that ARDS is heterogeneous in nature.
More encouraging results were observed when I studied patients earlier in the disease
process. In patients in the immediate post-operative phase following oesophageal
resection, I was able to demonstrate that the protein accumulation index obtained
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correlated with both the Pa02/Fi02 ratio and the circulating plasma elastase. This
work supports the role of the neutrophil as a key effector cell in the earliest stages of
acute inflammatory lung injury and is consistent with the contention that the first
steps in the initiation of acute inflammatory lung injury may occur within the
pulmonary intravascular space. I was, however, unable to demonstrate that the
occurrence of microvascular permeability is reflected by the circulating level of
several currently available endothelial markers although the development of
circulating markers of endothelial damage which are specific to the pulmonary or
systemic circulation should prompt further studies in this area. Circulating markers
which reflect damage to the epithelial barrier such as surfactant proteins or other
products of the alveolar epithelial cells may provide more appropriate markers
An important observation in this thesis is the number of negative values recorded for
PAI in the post-oesophagogastrectomy group. The possible explanations for this are
discussed in chapter 5 but is most likely to reflect the accumulation of indium-
transferrin which is probably associated with the oesophagogastric anastomosis and
is sampled by the heart probe. This explanation is supported by the frequent finding
of positive heart indium slopes in these patients which was not observed in either the
healthy volunteers or patients with ARDS (figures 5.5 - 5.14). Although, in
retrospect, this would seem a likely consequence of this technique it was unexpected
as the same principle had been employed in a similar patient group (Rocker et al.
1988 b) and in patients who had undergone cardiopulmonary bypass with median
sternotomy (MacNaughton et al. 1992) This may reflect the fact that the Nottingham
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group used a larger focused collimator and the London group redesigned the
collimation on the mini-scintillation detector (Hunter DN et al. 1990). Should these
studies be repeated it would be extremely valuable to adopt the protocol employed by
the Netherlands group in which serial venous sampling was used throughout the
study period to determine the activity of the circulating radionuclides and compare
these results to those obtained by the heart probe (Raijmakers et al. 1993).
Although the power of these studies is limited by the patient numbers, it seems
unlikely that the detection of elevated pulmonary endothelial permeability per se will
provide a reliable predictive indicator to the occurrence of impending acute lung
injury. Perhaps such hopes are unrealistic when one considers that it is the
pulmonary epithelium which represents the rate limiting step preventing alveolar
flooding and as such, increased endothelial permeability may depict a forme fruste
which may resolve without further consequence to the patient. Furthermore, both
ALI and ARDS, as currently defined, encompass a number of disparate conditions
which may evolve through different pathways. Thus a combination of indices with
predictive value should be tested to identify algorithms which may be applicable to a
broader patient groupings.
Finally, it is important to discuss whether the measurement of pulmonary
microvascular permeability is likely to be beneficial in the management of patients
with established ALI and ARDS. Currently the management of these patients is
largely supportive and does not depend on knowing, if and to what extent
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permeability is abnormal, it may be argued that no such measurement is necessary
and this is perhaps one reason that such techniques have not been widely applied. It
has been suggested that the degree of permeability reflects the severity of the
underlying lung injury and as such may have some bearing on prognosis (Velazquez
et al. 1991, Sinclair et al. 1994). If further studies can repeat these observations then
useful data relating to patient outcome might be expected. Furthermore, as new
therapies and ventilation strategies are applied in the setting of controlled clinical
trials it may be reassuring to know that they do not lead to an increase in
permeability.
Whilst this technique is unlikely to be useful within the setting of established ARDS,
the benefits of a reliable should be undisputed. As further mediators are described
within the inflamed and damaged lung it will be of important to recognise and
identify those which most reliably reflect the underlying pathophysiological
response. Furthermore, as we move to evaluate new therapeutic agents and
modalities, within the setting of controlled clinical trials, it may prove useful to
determine whether any intervention leads to a worsening of pulmonary permeability.
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